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ABSTRACT
Sodium deoxycholate (NaDC) is a small bile salt that was used in this
dissertation to produce gelation of tris(hydroxymethyl)amino-methane (TRIS) solutions
above, below, and near the pKa of NaDC. These solutions respectively yielded a neutral
gelator, a charged gelator, and a mixture of each. Impacts of ionic interactions on gel
formation were studied in detail and showed that pH can be used to modify many
hydrogel properties including sol-gel temperature, crystallinity, and mechanical strength.
It was also observed that pH modification of the hydrogels affected nanoparticle
formation. Nanoparticles derived from a Group of Uniform Materials Based on Organic
Salts (nanoGUMBOS), specifically cyanine-based NIR dyes, were templated within the
hydrogel network for potential applications in tissue imaging. These nanoGUMBOS
were found to be size-tunable, although material dependent.
Several hydrogel formulations yielded a unique rheological finding of two stable
regions of elastic modulus. Release of different solutes was investigated under different
hydrogel conditions and at variable shear rate. Temperature, solute size, hydrogel
formulation, and shear rate were all found to impact solute release. This suggests that
NaDC/TRIS hydrogels can be used as injectable, topical, or patch-type drug delivery
vehicles or as solute delivery vehicles in applications such as fertilizers and packaging.
Enantiopreferential drug release from these hydrogels was also examined.
Native gels exhibited significant release preference. This is of great importance to
pharmaceutical applications due to the prevalence of racemic drugs. It was found that
with facile modification, the enantiopreferential release could be inverted. Further
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understanding

of

NaDC/TRIS

gelation

has

broadened

the

tunability

and

multidimensional applications of these tailored hydrogel systems.
A three-component GUMBOS derived from fluorescein, rhodamine B, and
tetradecyltrihexyl phosphonium was synthesized and characterized. Nanoparticles
prepared from this GUMBOS exhibited dual-wavelength fluorescence. Ratiometric
analysis of these two emission bands revealed changes with pH, specifically between
the biologically relevant values of pH 5 and pH 7. Thus, fluorescence microscopy was
employed to image cancerous and normal breast cells incubated with nanoGUMBOS.
Higher uptake of nanoGUMBOS and more pervasive fluorescence intensity were found
in comparison to normal cells, showing great potential for fast, visual determination of
cancer cells.
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CHAPTER 1.
INTRODUCTION
1.1. Classifications and properties of hydrogels
“The colloidal condition, the ‘gel,’ is one which is easier to recognize than define.”
This immortal quote of Jordan Lloyd in 1926 is a statement that still holds true today.1
Hydrogels are prevalent in many areas of science and our everyday lives. For example,
they are used as sensors,2,3 in soft electronics,4,5 and in drug delivery6,7 in addition to
use in shampoo, diapers, and contact lenses. For this reason, many tests and
definitions have been developed for gel determination; yet all are incomplete or not fully
inclusive.1,8 One qualitative determination is the bubble rise test, in which a possible gel
is bubbled with air. If the bubbles move through the sample on the timescale of the
experiment, the sample is not a gel.9 On the other hand, more quantitative tests, such
as the modulus comparison test, rely on rheology.8 A common definition of a hydrogel (a
gel composed primarily of water or an aqueous solution) is a three-dimensional polymer
network capable of retaining large amounts water.10 This definition is, however,
incomplete. An important distinction must be made between polymeric hydrogels and
molecular hydrogels. The primary difference is the type of gelator, the molecule
immobilizing the water, as named. While there are many common characteristics
between these two classes, there are also many impactful differences.
Hydrogels of both classes tend to be viscoelastic, solid-like at low stress, and
primarily composed of water.11 It should be noted that there is a vast array of gelators
with an equivalent variety of properties. Polymeric gels can be composed of a covalently
crosslinked network of synthetic or biological polymers and generally have relatively
1

high mechanical strength. Molecular gels are often formed by noncovalent interactions
such as hydrogen bonding, π-π stacking, and hydrophobic interactions. However, some
molecular gels are covalently bound.12 The gelator of a molecular gel is often a low
molecular weight (LMW) molecule such as certain porphyrins13 or bile acids. Therefore,
these molecular gels are often referred to as LMW or physical hydrogels. Benefits of
such

gels

include

biocompatibility,

simple

and

inexpensive

synthesis,

thermoreversibility, and stimuli response.15 Each of these benefits is largely due to the
lack of chemical crosslinking.16 Polymeric hydrogels have vast applicability and benefits
(such as high mechanical strength), and will be discussed briefly in this work. However,
the focus of this dissertation will be on LMW hydrogels.
1.2. Development and types of molecular hydrogels
Of the currently known LMW hydrogelators, almost all have been discovered in
the past 20 years.12,17 Early examples were primarily found through serendipity. It is
only in recent years that they have been strategically designed. Design of LMW
hydrogelators began by formulating molecules with structural similarities to those found
serendipitously.12 For example, amphiphilic moieties and hydrogen bonding sites are
prevalent in gelator design. The ability to rationally design a gelator has increased the
application of hydrogels, because properties can be chosen to fit specific requirements.
The earliest known discovery of an LMW hydrogelator, uric acid, was
documented in an 1841 paper by Lipowitz.18 In 1892, Brenzinger found that dibenzoyl
cysteine could be used as an LMW hydrogelator.19 It has been suggested that such
systems were not of interest until recent years due to the lack of terminology to describe
and technology to understand the hydrogels.20,21 Several classes of molecules,
2

including amino acids,22,23 carbohydrates,24,25 and surfactants,26,27 were found to contain
hydrogelators. With an increasing number of LMW hydrogelators discovered and the
use of microscopy for visualization of gel structure, the 1900s saw a drastic increase in
attention towards LMW hydrogels.8 As a result, the natural desire to design LMW
hydrogelators increased as well.
Rational design of small molecule hydrogelators began by mimicking and
modifying organogelators (molecules known to gelate organic solvents) and
hydrogelators that had previously been found serendipitously.12,17 Common to most
hydrogelators are hydrophobic domains, such as the tails of many surfactants, and
hydrogen bonding sites, as in the hydroxyl groups of carbohydrates.12 It can be
expected then that any small molecule designed to be a hydrogelator might have one or
both of these properties. In 1999 and 2000, the Hamilton group, for example, converted
an organogelator to a series of hydrogelators by carboxylating and alkylating bis-urea.28
A few years later, the Hanabusa group similarly converted a group of L-lysine based
bis-amide organogelators to hydrogelators with the introduction of an ionic moiety, e.g.
a cationic nitroaromatic group.29 Once a hydrogelator was discovered, similar molecules
were often broadly screened for other hydrogelators. For example, a collection of
naphthalene-dipeptide hydrogelators was developed by the Adams group in 2010 by
varying three different substituent groups.30 As the library of LMW hydrogelators
increases, so does the number of potential applications and consequently the number of
hydrogelators designed for such specific functions.
Applications of hydrogels can be listed endlessly. This vast array includes drug
delivery,31,32 food (including processing and end-product),33,34 cosmetics,35 tissue
3

scaffolding,36,37 material templating,38,39 sensing,40-42 soft electronics,43,4 and optical
devices.44,45 It is important to realize that each application, even within the same
category of use, requires a discrete set of properties of the chosen hydrogel. For
instance, in tissue scaffolding applications the mechanical strength required of a gel can
vary greatly depending on the type of tissue being mimicked.46 It is for this reason that
tunability is a strong benefit. Tunability can come from either modifications to the gelator
as discussed, e.g. carboxylation or other functionalization, or from the addition of a
modifier to the hydrogel formulation. Either mode of tunability, or indeed a combination
of both, can provide the necessary characteristics for numerous applications.
While rational design of LMW hydrogelators began as an exploratory function,
focus has now shifted to the intentional development of molecules with desired
properties for use in a particular application. This approach has recently been aimed
toward the development of stimuli-responsive hydrogels.
1.3. Stimuli-responsive hydrogels
Stimuli-responsive hydrogels are gels that change characteristics, or “respond,”
when introduced to a stimulus. Common stimuli of interest include pH, light, and ion
concentration.47 Sol-gel transitions are the most commonly exploited change in stimuliresponsive hydrogels.14 However, volume changes,48 optical properties,49 swelling
kinetics,50 and conductivity51 can also be affected by stimuli. These responsive
hydrogels have gained recent interest because a change in physical or chemical
properties in response to specified stimuli can be useful in many applications. For
example, sensing and drug delivery can each be enhanced with stimuli-responsive
materials.
4

LMW, physical hydrogels are particularly suited for development into stimuliresponsive materials based on three characteristics as described by Jan van Esch and
colleagues12 First, the absence of covalent bonds between gelator molecules facilitates
reversible gelation. This can be exploited in response to various triggers. Second, if it is
well understood which moieties of the molecule participate in gelation, the gelator can
be modified to have varied and tunable properties. For example, alkyl chains are often
added for enhanced aggregation in aqueous media. Changes in chain length may be
used to change physical properties. Finally, gelator molecules self-assemble into highly
ordered patterns. These characteristics allow for the design of LMW hydrogels as
stimuli-responsive materials.
Sol-gel transitions that depend on pH are important in biological applications due
to the specific pH of different parts of the body and caused by different conditions, such
as the relative acidity of bacterial infections and cancer sites.47 Polypeptides have been
explored for these purposes by several groups.52-54 The sequence of amino acids can
be chosen such that sol-gel transitions take place at a wide range of pH values. A group
of LMW hydrogelators based on N-(fluorenyl-9-methoxycarbonyl)-D-alanine-D-alanine
have been shown to have a completely reversible sol-gel transition with change in pH.55
In addition to full sol-gel transitions, some hydrogel materials have been developed to
have pH-dependent shrinking and swelling.52,56,57 This can be exceptionally useful for
continued release in response to desired pH, rather than a single use system. A
common theme in the design of pH-responsive systems for drug delivery applications is
the use of pH-dependent moieties such as amines and carboxylic acids.6 In every case,
the ability to tune the transition pH for a desired application is ideal.
5

Response to temperature is another useful characteristic in hydrogels for drug
delivery.58 Among other uses, the most common is to employ a temperature induced
gel-to-sol transition to release drugs within the body or a sol-to-gel transition for
facilitated processing with the desired properties of a gel in vivo. Thus far, most work
towards temperature-responsive hydrogels has been with polymeric gelators. Poly(Nisopropylacrylamide) seems to be the most popular material base for this type of
application.59,60 Other common thermoresponsive gelators include similar structures
such as poly(N,N-diethylacrylamide)61,62 and copolymers including one or both of
these.6 In addition to phase transitions, thermally triggered volume changes (i.e.
swelling and shrinking) can also be useful in drug delivery. An interpenetrating network
of poly(acrylic acid) and polyacrylamide, for example, swells in response to increased
temperature, thereby changing the drug release rate.63,64 It is ideal if modifications (such
as changes in component ratio) can be made to the hydrogel system to modify these
responses to best fit individual applications. As more is understood about LMW
hydrogels, work with temperature response will follow.
While pH and temperature are common triggers for stimuli-responsive hydrogels,
response to other stimuli is gaining interest as well. Response to biomolecules is rapidly
gaining attention due to its specificity, especially systems for insulin release triggered by
glucose concentration.6 Hydrogels can also be designed to be responsive to light,65,66
mechanical stress,67 electrical field,68,69 and salt composition or concentration.70,71 The
utility of hydrogels is demonstrated by the multitude of hydrogel phase transition and
volume change triggers studied and a correspondingly high number of hydrogel
materials. It also further illustrates that the vast array of hydrogel applications requires
6

an equal array of hydrogel systems to choose from; ergo, the design of new, specifically
tunable, hydrogels is of the utmost importance.
1.4. Hydrogels in drug delivery
Hydrogels have long been investigated as drug delivery vehicles for two primary
reasons. First, their inherent similarities to biological membranes make them suitable for
such applications. Second, the wide range of hydrogel systems allows for diverse use
across many types of delivery. For these two reasons, hydrogels have been applied in
delivery systems ranging from wound dressings and topical applications to ocular and
gastrointestinal deliveries.32
The general similarity of hydrogels to biological membranes is a many-faceted
resemblance that can be made even stronger with intentional modifications. Arguably
the most important similarities are those of high water content and high porosity.72 The
combination of these two properties facilitates diffusion of oxygen, nutrients, and drugs
into sites of interest and diffusion of waste, heat, and dead cells out of the site.31
Furthermore, specific gelators can be chosen or designed for increased biocompatibility
and biodegradability. The development of stimuli-responsive hydrogels can be exploited
to further enhance drug delivery. The benefits and diversity of hydrogel systems allow
their broad application in several different types of drug delivery systems.
1.4.1. Modes of drug delivery
The requirements of drug delivery applications are at least as diverse and everchanging as the large number of systems currently available, if not more so. Therefore,
it is of great importance that new drug delivery vehicles are continually being designed
7

and explored. Different modes of delivery, such as gastrointestinal and ocular delivery,
as well as their corresponding requirements of a delivery system will be discussed
briefly as an example of the extent of this diversity.
Gastrointestinal environments are common targets of oral drug delivery.73 Robust
hydrogels are required for this type of application, because they need to protect drugs
from harsh digestive processes until the desired site of application is reached. In
addition to being robust, orally administered drug delivery vehicles also need to be
nontoxic.32 Polymeric gelators such as pectin,74 cellulose acetate,75 and other
biopolymers are often chosen for this reason. Because each section of the digestive
tract has a distinct pH,76 hydrogels responsive to pH are particularly useful for
gastrointestinal delivery.51 For example, a system can be designed such that it
degrades or swells at the pH value of the desired application site to release a drug.
LMW gelators such as chitosan and alginate gels have both been used in such
cases.77,78
Ocular delivery is a particularly challenging type of delivery due to the efficient
disposal processes and protective barriers of the eye. Topical applications to the eye
are often washed away or diluted due to the 75% loss of ophthalmic solution.79
Membranes such as the conjunctiva and three layers of the cornea inhibit passage of
foreign substances into the eyes and each has different requirements (e.g. polarity) for
transportation to occur.80 Injectable devices are one way to overcome these obstacles.
P(NIPAAm-co-Dex-Lactate HEMA) hydrogels, for example, were developed for
significant release when injected into the subconjuctival space of the eyes. Such
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administration circumvents the eye’s barriers, and the high release allows for sufficient
dosing after dilution processes.81
Transdermal delivery of substances to the body can be speculated to date back
to the body painting of our prehistoric ancestors.82 Modern use of transdermal delivery
began with a motion sickness patch in 1979 and has grown to include smoking
cessation aids, hormone therapy, birth control, and many other uses. It was estimated in
2008 that over one billion transdermal patches were produced per year.83 Transdermal
delivery overcomes the discomfort and expense of injectable drug delivery vehicles.
This type of delivery can also be used to avoid premature metabolism and harmful side
effects that may be encountered with oral drug delivery vehicles. As with ocular delivery,
the difficulty with transdermal application is the natural barriers that have evolved to
keep exogenous substances out.84 Hydrogels have been useful in the design of
transdermal patches due to the broad flexibility of their design,85 their ability to contour
to the application site, and their ability to be coupled with iontophoresis (a method of
applying an electric field to induce transport across the membrane).86 Poloxamer 407
gels were found to release peptide drugs such as insulin transdermally, enhanced by
coupling with iontophoresis. This study exhibits an additional benefit of using a gel
system in that chemical enhancers can be loaded within a gel system to further facilitate
drug transport through the skin.
Subcutaneous delivery has become a popular approach used to completely
bypass the skins natural barriers. Lee et al. designed triblock PEG copolymers for
subcutaneous antibody delivery.87 For subcutaneous delivery, it is desirable that
hydrogels be injectable at ambient conditions for facile administration. In many cases,
9

however, hydrogel materials are not injectable at ambient conditions, making
thermoresponsive properties desirable for subcutaneous applications. For that reason, it
is desirable to design hydrogels with sol-to-gel transition at body temperature for
subcutaneous injection, such as the chitosan/polyelectrolyte gels designed by
Matanovic et al. for heparin release.88
1.4.2. LMW benefits of hydrogels for drug delivery
As has been previously mentioned, LMW hydrogels can provide significant
enhancements in drug delivery applications. In many ways the synthesis of LMW
hydrogels, specifically, is superior to that of polymeric hydrogels when used for drug
delivery applications. For example, LMW hydrogels typically do not require harsh
initiation triggers because they are self-assembled.89,90 A common problem with
polymeric systems is the high probability of the presence of unreacted monomer,
typically a toxic molecule.91,92 The small molecules used to gelate aqueous solutions are
typically nontoxic, thereby eliminating this complication. Synthesis of LMW hydrogels
are often less expensive than comparable polymeric systems due simply to the
reduction of steps. Initiation, subsequent polymerization, and removal of unreacted
monomer and crosslinker are typically not required steps in the synthesis of LMW
hydrogels. Simple and inexpensive synthesis means that such materials can be used in
a multitude of more common applications in addition to vital or sophisticated
applications.
The absence of a chemical crosslinker in and of itself provides a multifaceted
advantage. Firstly, crosslinkers tend to be toxic, so any unreacted excess will be a
deficiency.72 Most importantly, however, are the properties resulting from the absence of
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chemical crosslinking, namely thixotropy and thermoreversibilty.93 Agitation and
temperature can each temporarily disturb the physical interactions immobilizing an LMW
hydrogel. However, the reestablishment of hydrogen bonding, π-π stacking,
hydrophobic interactions, etc. will occur over time, thereby gelating again. Because this
“physical

crosslinking”

is

more

easily

perturbed

than

a

chemical

crosslink,

biodegradation and excretion from the body are typically superior in LMW hydrogels.17
As with all hydrogel applications, it is important to note that different properties
are beneficial for different types of drug delivery applications. Drug delivery can be
categorized by the route of delivery. Wound dressing, subcutaneous, ocular, oral, and
surgical implantations are a few representative types of delivery, each with specific
needs from a delivery system. Hydrogels used as wound dressings for example, should
have maximum porosity for removal of waste and transfer or oxygen, drugs, and
nutrients.94,95,96 They should also be deformable, as opposed to a rigid gel, in order to
increase contact area (thereby facilitating molecular and heat diffusion further), and to
provide a physical barrier to microbes and physical damage.97,98 Ocular delivery, on the
other hand, requires a hydrogel that can withstand the rapid degradation processes of
the eyes. This can be attained through use of a more rigid contact lens.99
LMW hydrogels exhibit properties that make them beneficial for many types of
drug delivery.31,32,100 Facile, inexpensive synthesis makes them widely applicable, while
the absence of chemical crosslinking provides additional benefits. Thermoreversibility,
thixotropy, simple biodegradation, and biocompatibility all enhance LMW hydrogels
toward drug delivery applications. The wide variety of available LMW gelators also
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allows for selection of properties suited for a specific desired application. Bile salts are
one example of LMW gelator and will be explored further in this dissertation.
1.5. Bile salt gels
Bile salts are a class of molecules found in the liver of most vertebrates. Their
ability to form micelles contributes to digestion, dietary fat absorption, cholesterol
elimination, and other metabolic processes.101 This type of salt comprises a large family
of molecules, but all are derived from cholesterol and consequently share some of its
characteristics. Cholesterol and all bile acids have a steroid backbone. This includes
three six-membered rings and one five-membered ring (see Figure 1.1) and a five- or
eight- carbon side chain often ending in a carboxyl group. Variation between different
members of this class can be due to varied hydroxylation and leads to different
properties and, consequently, functions.

Figure 1.1. Structure of cholesterol.
Bile salt media is used to distinguish pneumococcus (the pneumonia-causing
bacteria) from other cocci (spherically-shaped bacteria) based on dissolution.102,103 The
serendipitous discovery of bile salt hydrogelation was first documented through this use.
Harry Sobotka and Nina Czeczowiczka were consulted about this discovery and, in
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1958, published the first study investigating bile salt hydrogels.104 The gelation of
deoxycholic, cholic, glycocholic, and lithocholic acid was explored. They found that
deoxycholic and lithocholic acid each formed gels while the others did not. A cholic acid
trimer (tripodal cholamide), however, was found by Uday Maitra and colleagues to
gelate water and aqueous solutions.105 As is found throughout the literature, this is an
indication of the sensitivity of LMW physical hydrogels. For gelation to occur there must
be a delicate balance between the hydrophobic and hydrophilic moieties and between
the physical interactions immobilizing the network.17 Moreover, even molecules that do
exhibit the needed balance require certain conditions for gelation. With bile acids for
instance, a relatively low pH is often needed to increase the aggregation number
sufficiently for gelation.
Gelation

by

these

molecules

can

be

attributed

to

several

of

their

characteristics.11,106 Bile acids have a relatively hydrophilic convex face due to the
presence of hydroxyl groups. They also have a relatively hydrophobic concave face due
to the presence of aliphatic groups. This results in a facial amphiphilicity that imparts
hydrophobic interactions and, consequently, aggregation. Additionally, hydroxyl groups
can participate in hydrogen bonding, further ordering a bile salt solution.
Despite the fact that bile salt gels have been around for several decades,
significant work is still being done on their development. This widespread interest is due
in part to the fact that bile salts are highly derivitizable.14 This means that systems can
be facilely designed and tuned for specific applications. Applications of bile acid gels are
widespread and include everything from sensing materials to nanoelectronics to drug
delivery systems.
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From about 1958-1960, Blow and Rich did pioneering work on the understanding
of the gelation mechanism of bile salts, specifically sodium deoxycholate.107,108 It was
found that gelation of deoxycholate solutions is related to the surfactant properties of
the molecule and the resultant micelle formation. Unlike typical micelles, deoxycholate
molecules form “huge,” helical micelles with regular intervals. The large helices
(determined to be 36 Å) are relatively rigid and, most importantly, have a large degree
of molecular specificity in relation to typical micellar systems. That is to say, small
changes to the deoxycholate structure can result in a complete destruction of the
complexing process. Another important distinction between a typical micelle and
deoxycholate hydrogels is the observation of crystalline spacing. While soap solutions
are determined to be “liquid,”109 deoxycholate gels exhibit a definite crystalline spacing
when analyzed by X-ray diffraction. These findings were critical for the further
understanding, development, and application of deoxycholate hydrogels.
Uday Maitra is a leader in the field of bile acid gels. His group has done work with
several different bile acid gelators under many sets of conditions. 105,106,110,111,112 Goals
of this group include development of a broad array of systems for various applications in
addition to further understanding the properties of the gel, including structure and
dynamics. The Maitra group employed a battery of techniques in order to characterize
these materials. This includes spectroscopy techniques (e.g. steady-state and timeresolved fluorescence, dynamic light scattering), mechanical techniques (e.g. rheology,
viscometry), and other techniques such as electron microscopy and neutron scattering.
Bile acid gels have a long history of development that still continues in current
research, as evidenced by the continual publication of research articles, books, and
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review papers. Gelators have been designed and discovered with neutral, cationic, and
anionic side chains.72,113,114 Gelation has been found to be influenced by many factors.
One such factor is the pH value of the aqueous solution to be immobilized.115 In almost
all cases, a more acidic solution enhanced strength and speed of gelation. Salt
concentration was also found to influence many systems. However, this is a more
complicated factor. In some cases, salt enhances gelation116 while in others, it disrupts
or inhibits it.117 As previously mentioned, the most important thing to note about such
varied systems is that each profile of properties can be suited toward specific
applications.
The applications of bile acid gels are as many and varied as the number of
systems available. Common applications can be categorized into groups including use
as rigid platforms, molecular recognition devices, separation membranes, synthesis
templates, use in optoelectronics, and biological applications. Some examples will be
described herein; however, there are many review articles that discuss these
applications in detail. 118-122
Rigid platforms, such as a hydrogel, can be used to direct molecular orientation
and immobilize molecules within a network. The Shinkai group, for example, utilizes this
immobilization for use as a fluorescence-based pH sensor.123 A fluorescent moiety,
1,10-phenanthroline, was incorporated into a cholesterol-based gel. Both fluorescence
intensity and emission wavelength were found to change with proton concentration in
this study. Due to the immobilization properties of the hydrogel network, the rigid
platform can also be used for the promotion of electronic energy transfer.110
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An emerging use of bile acid hydrogels is for the templating of nanomaterials
synthesized within the hydrogel network. Bhattacharya, a leader in the field of bile acid
gels, used stearic acid-based hydrogels for controlled templating of silver
nanoparticles.124 Bile acid hydrogels are well suited for nanotemplating because of their
well-defined and easily tunable properties. Bhat and Maitra have also used thiolated
cholic acid-based hydrogels to template and stabilize gold nanoparticles.111 This is an
important application of hydrogel materials due to the many uses of metal
nanoparticles.
Bile acid hydrogels are particularly well-suited for biological applications due to
their high water content, porosity, and biocompatibility. Drug delivery will be discussed
in detail in the following sections. Other biological applications include use as artificial
tissues125 and cell immobilization. Cell immobilization not only utilizes, but requires, the
high porosity and rigid mesh network of a hydrogel. Cells are large enough that they
are “macroencapsulated” within the gel network.126-128 The porosity allows for diffusion
of nutrients and oxygen into the cells and waste and heat out of the cells.46
Regardless of the category of application, stimuli-responsive bile gels can be
used for enhancement. As discussed with other stimuli-responsive materials, bile gels
have been designed to respond to external stimuli such as light,129 temperature130,112
and pH with changes in phase, color, or volume. The Kolehmainen group, for example,
has designed a stigmasterol-based hydrogelator that has a sol-gel transition triggered
by acidification.131 Conversely, Liu et al. designed a cholesteryl glycinate-based
hydrogelator that has a sol-gel transition with the addition of a base.132 The multitude of
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bile acid gelators and their endless tunability provide potential for design of many
stimuli-responsive bile gel materials.
1.5.1. Bile salt gels in drug delivery
Thus far, bile gel drug delivery has not been exhaustively explored, although
some important work has been published indicating great potential. The BernkopSchnürch group was the first to evaluate sodium deoxycholate hydrogels for their use
as drug delivery vehicles.133 Release of the model drug rutin was examined and
determined to be affected by sugars such as mannitol. Deoxycholate hydrogels were
found to enhance permeation in this case. This property can be extremely beneficial for
increasing drug uptake. Due to the many potential benefits of bile salt hydrogels and the
lack of research using them, there is a significant opportunity for exploration in this field.
1.5.2. Benefits of NaDC/TRIS hydrogels
The primary focus of this dissertation is the development and exploration of
sodium deoxycholate (NaDC)/tris(hydroxymethyl)aminomethane (TRIS) hydrogels.
These hydrogels are LMW and physically crosslinked, meaning that they have all the
advantages associated with such systems as previously described. In addition to
thixotropy, thermoreversibility, biocompatibility, etc., they also exhibit a host of other
benefits that make them suitable for drug delivery and other applications. These
beneficial properties will be discussed and demonstrated at length in the following
chapters. In summary, NaDC/TRIS hydrogels are highly tunable with facile
modifications, injectable at room temperature, optically transparent, and can be loaded
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with drugs or other materials concurrent with gelation. Therefore, NaDC/TRIS hydrogels
are exceptional candidates for a multitude of applications.
1.6. Group of Uniform Materials Based on Organic Salts for biomedical
applications
Hydrogels are only one example of interesting materials for biomedical
applications. A Group of Uniform Materials Based on Organic Salts (GUMBOS) also
show great promise and utility in the field of biomedicine. The term GUMBOS refers to
organic salt materials with a melting point range of 25 to 250 °C renowned for tunability
and broad applicability.134-138 In some respects, GUMBOS may be thought of as solid
phase ionic liquids since the same counterions are often used in both. Primary
differences lie in the melting point range of these organic salts. While applications of
ionic liquids are extensive due to longer existence, GUMBOS have more recently
proven useful in applications as varied as solar cell sensitization139 and molar mass
sensing of volatile organic compounds by use of quartz crystal microbalance.140 This
dissertation will involve discussion and application of GUMBOS for biomedical
applications. Thus far, GUMBOS have been used in at least three notable ways toward
this field. Li et al. exploited the facile tunability of GUMBOS to incorporate luminescent
and paramagnetic properties into several GUMBOS found to selectively target cancer
cells in vitro.141 The inhibition of growth in tumor cells was attributed to a cation choice
of aryltriphenylphosphonium. Tunability of GUMBOS has also been exploited by Magut
et al., demonstrating an improvement in selective cytotoxicity toward cancer cells with a
simple change in anion.142 Das et al. have investigated the intersection of two exciting
materials, GUMBOS and LMW hydrogels.143 In that study, LMW hydrogels were shown
to provide a tunable template for nanoGUMBOS synthesis. Nanoparticle size and
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spectral properties were found to be tunable in ways pertinent for a variety of biomedical
applications. For example, fluorescence emission wavelength was tuned with slight
modification to the hydrogels. These exceptional materials, GUMBOS and hydrogels,
show great potential for biomedical applications ranging from imaging to drug delivery
vehicles to active drugs. Both will be explored further in this dissertation.
1.7. Instrumentation
1.7.1. Ultraviolet-visible spectroscopy
Ultraviolet-visible (UV-vis) spectroscopy is an analytical technique used for
qualification and quantification of molecules that absorb light in the UV-vis range of the
electromagnetic spectrum, from about 200-800 nm. UV-vis spectrophotometers are
typically comprised of a light source, monochromator, sample holder, and detector
(Figure 1.2). Light from the source is passed through a monochromator so that
absorption can be measured at distinct wavelengths. The filtered light reaches the
sample, and a portion of the light is transmitted through the sample and measured by
the detector, typically a photomultiplier tube or a photodiode. Transmission (T) is the
ratio of incident light (I0) to transmitted light (I), and absorbance (A) is calculated as the
negative natural log of transmission.

Beer-Lambert’s law can be used to calculate sample concentration from absorbance
using the equation A=εbc, where ε is the molar absorptivity coefficient characteristic of a
molecule, b is the pathlength of the light through the sample, and c is the concentration
of the molecule in the sample.
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Figure 1.2. Schematic representation of a UV-vis absorbance instrument.
1.7.2. Fluorescence spectroscopy
Fluorescence is a phenomenon associated with radiative transitions of a
molecule between energy states of the same multiplicity, for example from the excited
S1 singlet state to the ground S0 singlet state. Fluorescence spectroscopy is a technique
used to measure and analyze the radiative light emitted during this phenomenon. For
aromatic hydrocarbons, fluorescence occurs on a timescale of 10-9 seconds. A
proportionality constant called quantum yield (φf) can be used to describe the ratio of
photons that fluoresce to the number that was absorbed:
#
#
Fluorescence and related processes are commonly illustrated in a Jablonski diagram
(Figure 1.3). Absorbance (A) and fluorescence (F) are depicted along with the
competing processes of internal conversion (IC), intersystem crossing (ISC), and
phosphorescence (P). IC is a nonradiative decay between two coupled vibrational
states of different energy levels. ISC is also a nonradiative transition occurring between
two states of different multiplicities, promoting phosphorescence. Phosphorescence
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occurs after ISC to a different multiplicity (e.g. singlet to triplet). It typically occurs on a
much slower time scale than fluorescence because it is a kinetically unfavored
transition.

Figure 1.3. Jablonski diagram depicting absorbance (A), fluorescence (F), and
competing processes (IC, ISC, P).
Instrumentation for fluorescence spectroscopy is typically configured in a right
angle geometry (Figure 1.4) Typical light sources include mercury or xenon arc lamps.
Light passes through a monochromator before reaching the sample. Light emitted at 90°
from the incident light is primarily passed through a second monochromator and
collected. Photomultiplier tubes are often used for signal amplification before data is
sent to the computer for processing.
1.7.3. Differential scanning calorimetry
Differential scanning calorimetry is a type of thermal analysis in which the
difference in heat flow between a sample and a reference is measured as a function of
temperature. Small aluminum pans containing the sample and reference materials are
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Figure 1.4. Schematic diagram of a fluorescence spectrophotometer.
heated concurrently in a sample chamber. Typically, heating is computer controlled and
linear at a specified rate, for example 5 °C/minute. Thermocouple junctions are used to
quantify the differential heat flow of the sample and reference. The resulting output from
the computer is a thermogram (Figure 1.5), a plot of temperature versus differential heat
flow.
Applications of DSC often include investigation of transitions. For example,
melting point onset and maximum melting temperature can be found through DSC.
Similarly, DSC can be used to determine the glass transition temperature. For
amorphous materials, this is the temperature at which the material reversibly transitions
between a flexible state and a brittle state. Through integration of thermogram curves,
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the enthalpies of transitions can be found as well. DSC can also be used to obtain
information on crystallization such as degree of crystallization and changes in crystalline
phase, such as with dissolution. Similarly, formation of liquid crystals or eutectic points
can be determined as well. The many applications of DSC have been used in industries
such as pharmaceuticals for determination of drug purity and food industries for
processing and packaging temperatures. Any event, chemical or physical, that results in
a change of heat flow (exo- or endo-thermic) can be considered for DSC evaluation.

Figure 1.5. Depiction of a thermogram including typical transitions. Note that in a
thermogram, endothermic transitions may be represented as “up” or “down” with
exothermic transitions being the opposite.
1.7.4. Polarized optical microscopy
Polarized optical microscopy (POM), also called cross-polarized light microscopy,
is a technique used for visualization of birefringence, typically giving information about
23

the crystallinity of a material. The apparatus is that of a typical optical microscope with
the addition of a pre-sample polarizer and a post-sample polarizer, often called an
analyzer. The unfiltered light source vibrates at all angles along an axis until it reaches
the first polarizer, reducing the vibration to one plane. The second polarizer is set at 90°
(hence “cross-polarized”), so that only light that has been split from the original plane is
observed. Birefringence is an indication of crystallinity. Therefore, the images obtained
reveal the organization and geometry of a material’s crystal packing. A sample that
does not exhibit birefringence, such as an amorphous material, will result in a dark
image.
1.7.5. X-Ray diffraction
X-Ray diffraction (XRD) is an analytical technique based on diffraction of x-rays
in a crystalline sample. Bragg’s law describes a condition of scattering in which:
2 sin .
where n is an integer, λ is the incident wavelength, d is the distance between planes of
the sample crystal, and θ is the beam angle. In order to fit this law, the interplanar
distance must be approximately equal to the incident wavelength. Resulting diffraction
patterns can give information on the phase of the sample material, the spatial
arrangement of atoms within a crystal, and, with use of a database, the chemical
makeup of a sample. Degree of crystallinity can also be determined using the intensity
of scattering. The instrumentation is parallel to any spectroscopic method in that there is
a source, a filter or monochromator, a sample holder, a detector, and a processor
(Figure 1.6). X-rays are typically produced by a cathode ray tube. When the incident
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beam reaches the sample, any crystallinity that obeys Bragg’s law will result in a
diffracted beam. The pattern is typically processed as 2θ versus electron counts and
can be used as a fingerprint for a particular substance.

Figure 1.6. Schematic diagram of an x-ray diffractometer. An x-ray source bombards a
sample, and the diffraction pattern is recorded.
1.7.6. Transmission electron microscopy (TEM)
Electron microscopy is a technique used to overcome the resolution limitations of
typical optical microscopes by using an electron beam under vacuum instead of a light
beam. Due to the enhanced magnification, electron microscopy has become a valuable
tool for the visualization of nanoscale materials. An electron gun generates an electron
beam that is focused on the sample using a series of lenses (Figure 1.7). Samples are
thinly coated onto a grid often composed of carbon-coated copper. In transmission
electron microscopy (TEM), the electrons transmitted by the sample are captured as an
image by a phosphorescent screen and a charge-coupled device (CCD). Consequently,
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areas of the sample that are denser result in a darker image, while areas that are less
dense result in a brighter image.

Figure 1.7. Schematic diagram of a transmission electron microscope. The yellow
represents the path of the electron beam through sample and lenses.
1.7.7. Rheology
Rheology is the study of the flow properties of a material. In a typical experiment,
stress is applied to a material while the resulting strain is measured. One type of
instrumentation does this with a parallel plate geometry (Figure 1.8). This analytical
technique can be used to gain understanding of complex structures such as colloids
and suspensions. Behaviors such as thixotropy, shear thinning, or shear thickening can
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be analyzed by rheology as well. Essentially, rheology is useful for viscoelastic
materials, those that exhibit both fluid-like and solid-like responses to stress.
Viscoelasticity is represented by the complex modulus, G*. The complex modulus is
composed of two moduli, the viscous or loss modulus (denoted G”) and the elastic or
storage modulus (denoted G’). The terms viscous and elastic refer to the solid- or liquidlike behavior of the material. The terms loss or storage refer to whether energy is stored
in the material or released as heat. The scope of applications of this technique is
extremely broad and varied. Within this dissertation, rheology is used to determine the
mechanical strength of hydrogel materials as determined through examination of the
elastic modulus and for a controlled rate of shearing.

Figure 1.8. Diagram of a plate geometry rheometer. The sample of interest (yellow) is
pressed between a sample holder and an oscillating plate.
1.8.

Scope of the dissertation
In this dissertation, I explore the use of two new materials in a variety of

biomedical applications – NaDC/TRIS-based hydrogels and two different GUMBOS.
Chapters 2 and 3 are an examination of the characteristics and delivery applications of
a new class of materials, sodium deoxycholate/TRIS-based hydrogels. In Chapter 2, the
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effects of modifications to the pH and concentration of the buffer solution on the
properties of the resultant hydrogel were evaluated. A broad range of analyses including
thermal and mechanical measurements was performed to better understand the
characteristics of these materials. These materials were also evaluated for their use in
templating organic nanoparticles derived from GUMBOS. Preliminary studies also
probed the use of NaDC/TRIS hydrogels for use as injectable drug delivery vehicles. In
the third chapter of this dissertation, several formulations of NaDC/TRIS hydrogels were
evaluated as sustained release devices. The effect of shearing was tested to determine
the utility of the materials as injectable or spreadable drug delivery devices compared to
implanted or dressing applications. The effects of drug size, temperature, and loaded
drug concentration were also examined. The use of NaDC/TRIS hydrogels for
enantioselective drug release is also investigated in this chapter. In addition to
preferential release of one enantiomer in the native state, modifications were also found
to switch the preferential release to the other enantiomer. Chapter 4 is a description of
the synthesis of a three component GUMBOS derived from fluorescein, rhodamine B,
and tetradecyltrihexyl phosphonium. Nanoparticles of this material were explored as a
ratiometric, FRET-based pH sensor with particular sensitivity between the biologically
relevant pH values of 5 and 7. Fluorescence microscopy of these nanoGUMBOS varied
greatly between cancer and normal cells, indicating incredible potential for use of these
nanoGUMBOS in visual diagnosis of cancer
1.9.
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CHAPTER 2.
SODIUM DEOXYCHOLATE HYDROGELS: EFFECTS OF
MODIFICATIONS ON GELATION, DRUG RELEASE, AND
NANOTEMPLATING*
2.1. Introduction
Bile acids such as sodium deoxycholate (NaDC) have long been known as
hydrogelators.1,2 However, it is only during the past couple of decades that low
molecular weight (LMW) gelators, such as some steroids, have been studied
extensively.3 Steroids (including bile acids) are composed of a tetracyclic ring system
with functional groups often including hydroxyl groups and an aliphatic side chain.4 The
rigidity of the steroid backbone and the stereochemistry of hydroxyl functionalities result
in facial amphiphilicity in NaDC, thereby enhancing formation of aqueous pools
immobilized by a hydrophobic gel network.5 In pure water, the gelation mechanism of
NaDC is considered to result from primarily entangled micellization,6 forming an overall
helical structure.1 The addition of a modifier such as TRIS7 or mannitol8 has been
shown to contribute hydrogen bonding to this gelation mechanism.
In addition to NaDC, LMW gelators include chitosan,9 azo dyes,10 nucleoside
derivatives,11 and many others.12 The myriad of LMW gelators allow a broad array of
applications

such

as

nanofabrication,13,14

biomedical

engineering,15

separation

science,16 and sensing.17 Development of a more diverse group of gels through
mechanical and thermal experimentation is essential due to such broad applicability.18,19

*This chapter previously appeared as “McNeel, K. E.; Das, S.; Siraj, N.; Negulescu, I. I.;
Warner, I. M., Sodium Deoxycholate Hydrogels: Effects of Modifications on Gelation,
Drug Release, and Nanotemplating”. Reproduced with permission from The Journal of
Physical Chemistry B 119 (27), 8651-8659. Copyright 2015 American Chemical
Society.
41

It has been established that polymeric hydrogels are typically stronger in durability due
to covalently cross-linked polymerization, making them more useful for actuators and
other material applications.20 The physicochemical interactions of LMW hydrogels are
much weaker in terms of durability; thus an increase in mechanical strength may be
desirable, especially for bioengineering.
Gels with variable mechanical strengths are expected to provide variable
templating capabilities for nanoparticle fabrication. The ability to develop a hydrogel with
a designable template is of importance to nanoscience due to the many useful
properties of nanoparticles dictated by particle size.21,22 These properties have been
found to include surface control and interaction with cells and other physiological media
making

nanoparticles

applicable

in

biosensors,

drug

delivery

systems,

and

bioengineering.22,23 Nanoparticles derived from a Group of Uniform Materials Based on
Organic Salts (GUMBOS), i.e. nanoGUMBOS, have previously been formed by use of a
variety of methods.24,25,26 This class of materials, GUMBOS, are solid phase materials
with tunable properties similar to ionic liquids. However, GUMBOS differ from ionic
liquids in that they are primarily used in the solid state and have melting points between
25 and 250 °C.21 An exponentially increasing number of applications27 including optical
electronics,21-30 biological imaging,24 solar cell sensitizing,31 cancer targeting,21,32
antibacterial,33 and molecular weight sensing functions34,35 make GUMBOS an
interesting class of materials to study. Das et al. have recently studied NaDC/TRIS
hydrogels

as

templates

for

size-tunable

preparation

of

organic

GUMBOS

nanoparticles.7 In their method, hydrophobic nanoGUMBOS are formed similarly to a
reverse micelle synthesis without a surfactant.7,36 The GUMBOS of greatest interest are
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in a water miscible solution (e.g. ethanol). Thus, the solvated GUMBOS preferentially
moves to hydrophilic pockets consequently forming nanoGUMBOS. Thus far, neither
the composition of GUMBOS nor the pH of the hydrogel have been shown to affect the
resultant size of nanoGUMBOS templated by these materials.
In this study, I desire to further understand the modified gelation mechanism and
expand the applicability of NaDC/TRIS hydrogels by investigating new materials under
previously unknown conditions. Herein, I report the pH dependence of gelation at
various TRIS concentrations through investigations of two distinctly different pH values:
pH 5.5 well below the pKa of NaDC2, 37 and pH 7.4, the physiological pH, which is above
the pKa of NaDC. An intermediate pH value of 6.8, i.e. near the pKa of NaDC, was also
investigated. Each pH value was found to yield different properties in the resultant
hydrogels indicating that ionic interactions are an important factor contributing to the
gelation process. Through investigation of gelation, several properties were found to be
tunable towards desired applications including sol-gel temperature, mechanical
strength, templating capabilities, and viscoelasticity. NanoGUMBOS derived from three
different NIR dyes were synthesized, and it was determined that hydrogel conditions
and GUMBOS composition influenced particle size. Unique viscoelastic properties were
found that prompted further investigations of small molecule release. Namely, two
stable regions were found in the elastic modulus of several formulations, indicating
great potential as injectable drug delivery vehicles. In order to demonstrate the utility of
this property, fluorescein release was examined in gels that had and had not been
sheared.
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2.2. Experimental details
2.2.1. Materials
Sodium deoxycholate (NaDC), tris(hydroxymethyl)aminomethane (TRIS), 6propionyl-2-(dimethylamino)naphthalene (Prodan), 8-anilino-1-naphthalenesulfonic acid
(ANS),

1,1′,3,3,3′,3′-hexamethylindotricarbocyanine

(HMT)

iodide

(97%),

bis(trifluoromethane)sulfonimide (NTf2) lithium salt, and bis(2-ethylhexyl) sulfosuccinate
(AOT) sodium salt (≥ 99%), were purchased from Sigma Aldrich and used as received.
Sodium tetraphenylborate (TPB) was purchased from TCI America and used as
received. Ultrathin Carbon Type-A copper grids (CF400-Cu; Ted Pella, Inc.; Redding,
CA) were used for TEM imaging. Triply deionized water (18 MΩ cm) was obtained from
an Aries Filterworks high purity water system and used for all experiments.
2.2.2. Selection of hydrogels
TRIS buffer solutions were prepared at concentrations of 25, 50, 100, 200, 250,
300, 400, and 500 mM. By use of concentrated and/or dilute hydrochloric acid, each
concentration was adjusted from an initial pH value greater than 10 to each of four pH
values: 5.5, 6.0, 6.8, and 7.4, generating a total of 32 individual samples. Solid NaDC
was added to each solution to provide a concentration of 20 mM, followed immediately
by 30 seconds of vortexing. Each sample was then bath sonicated for 20 minutes. The
samples were allowed to stabilize at 5 °C overnight before analyses. Hydrophobicity
studies using the fluorescent probe Prodan were employed for determining which of the
32 samples would be pursued for further study (Table 2.1).

44

Table 2.1. Concentrations of TRIS buffer at each pH value selected for study.

pH 5.5
pH 6.0
pH 6.8
pH 7.4

TRIS concentration (mM)
25, 100, 200, 250, 300, and 500
25, 100, 200, 300, and 500
50, 100, 200, and 400
25, 100, 200, 300, and 500

2.2.3. Characterization of hydrogels
Hydrogels were characterized using several techniques. X-ray diffraction studies
were performed on air-dried hydrogels using a Brüker/Siemens D5000 automated
powder X-ray diffractometer, and diffraction patterns were analyzed using MDI Jade
9.4.5 software. An Olympus BH polarizing optical microscope with an MD 1900 camera
was used to obtain POM micrographs. The polarizer was set to 90°, and the analyzer
was set to 0°. The hydrogels were drop-cast onto pre-cleaned glass slides and left to
dry, with a thin layer remaining after solvent evaporation. A Thermal Analysis (TA)
differential scanning calorimeter 2920 was used to determine sol-gel temperatures.
Samples were heated in hermetic pans from 10 °C to 80 °C at a rate of 2 °C per minute.
A TA AR 1000 rheometer (TA Instruments, Inc., Waters Corp., New Castle, DE) with
stainless steel plate geometry was used to determine the rheological properties of the
hydrogels, specifically the G’ and G” moduli. The fluorescent probe ANS was used to
characterize the rigidity of hydrogel fibers and size of aqueous pools through
fluorescence anisotropy (r) measurements. Fluorescence anisotropy is a measure of the
average angular displacement of a fluorophore, i.e. ANS in this study, which is given by
the equations:
,
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Anisotropy values can vary between -0.2 and 0.4, where -0.2 indicates free rotation and
0.4 indicates completely restricted rotation. To acquire these measurements, the light
source is polarized either vertically (v) or horizontally (h) before absorption, and the
emission is polarized either parallel or perpendicular to the source polarization. In my
studies, ANS was excited at 360 nm, and values of fluorescence anisotropy were
calculated at 430 and 520 nm.
2.2.4. Synthesis and characterization of [HMT][NTf2] and [HMT][TPB] GUMBOS
The GUMBOS [HMT][NTf2], [HMT][TPB], and [HMT][AOT] were synthesized
using a metathesis reaction, commonly referred to as an anion exchange method.24
Characterizations of GUMBOS were performed using

1

H (Bruker Avance 400,

CDCl3) and 19F NMR (Bruker DPX 250, CDCl3).
2.2.5. Synthesis of nanoGUMBOS in NaDC hydrogels
After addition of 20 mM NaDC to each TRIS solution, a 1 mM ethanolic solution
of [HMT][NTf2] was injected to achieve a final concentration of 20 µM. The solution was
then vortexed for 30 seconds, and followed immediately with 20 minutes of bath
sonication. The hydrogel samples were then allowed to stabilize overnight at 5 °C
before further study.
2.2.6. Characterization of NanoGUMBOS: Size and Morphology
A JEM-1011 (JEOL USA, Inc., Peabody, MA) transmission electron microscope
was used to obtain micrographs in order to examine the morphology of the prepared
nanoGUMBOS. Each hydrogel sample was drop-cast (100 µL) onto a TEM grid. Upon
drying, the grids were washed with water to remove the hydrophilic gels leaving behind
the hydrophobic nanoparticles. The grids were left to dry before obtaining TEM
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micrographs. ImageJ was used to determine statistical data on the particles including
average sizes and standard deviations.
2.3.

Results and discussion

2.3.1. Characterization of hydrogels
In order to investigate the use of modified NaDC hydrogels as templates for
synthesis of nanoGUMBOS and to determine their potential for other applications,
including material applications, physical characterizations were necessary. Using visual
observation, it was clear that the hydrogels varied in structural integrity after various
modifications to TRIS concentration and pH of the medium (Figure 2.1). For example, a
gel with 25 mM TRIS demonstrated “gel-like” behavior when at pH 5.5. However, the
same concentration of TRIS at pH 7.4 displayed significant fluidity, or a more “liquidlike” behavior. In addition, a gel with 300 mM TRIS at pH 7.4 demonstrated “gel-like”
behavior. Lowering the pH value has been shown to increase NaDC aggregation,
thereby aiding gelation.38 Therefore, gelation has mostly been reported in acidic
environments. However, this study demonstrates gelation at the physiological pH for
higher TRIS concentrations. Thus, it is evident from this study that TRIS is not only
modifying the gel microenvironment in acidic pH, but is also capable of inducing gelation
at

physiological

pH,

i.e.

above

the

pKa

of

NaDC.

The

morphology

and

microenvironment, as well as thermal and mechanical properties were investigated in
more detail and are further discussed below.
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Figure 2.1. Visual comparison of structural integrity of transparent NaDC hydrogels
containing blue [HMT][NTf2] nanoparticles prepared at (A) pH 5.5, 25 mM TRIS; (B) pH
7.4, 25 mM TRIS; and (C) pH 7.4, 300 mM TRIS.
2.3.2. Hydrophobicity and anisotropy studies with fluorescent probes
Prodan is a neutral, fluorescent, and hydrophobic probe used to evaluate the
microenvironments of these modified hydrogels. Prodan exhibits a fluorescence
maximum at about 400 nm in a hydrophobic environment and a maximum at about 530
nm in a hydrophilic environment.39 Determining the hydrophobicity of the hydrogel
microenvironment provides information regarding structural changes from one hydrogel
to another. Examination of the fluorescence spectra of 10 µM Prodan within the
hydrogels (Figure 2.2), suggested differences in microenvironments. Among hydrogels
with similar hydrophobicity (as exhibited by the fluorescence spectra) one was selected
for further studies (Table 2.1). In general, the hydrophilicity of the microenvironment
experienced by Prodan increased with increasing TRIS concentration. Given the mode
of gelation, this shows that increasing TRIS concentration leads to an increase in the
size of aqueous pools formed between the hydrophobic fibers of the hydrogel. This
trend was not observed for pH 7.4, however, at which each concentration of TRIS had
approximately the same hydrophobicity with slight variations in intensities. Based on this
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observation, I suggest that the gel microenvironments at various TRIS concentrations
are not significantly different at pH 7.4. Based on these data, one TRIS concentration
was selected from each cluster of intensities for further investigation.
B)

A)

Figure 2.2. Emission spectra of the fluorescent probe Prodan in hydrogels at A) pH 5.5
and B) pH 7.4. Samples were excited at λex = 360 nm.
The hydrophobicity probe ANS was used to determine the degree of anisotropy,
or restricted rotation, in each hydrogel. This probe exhibits emission maxima near 430
nm and 520 nm in hydrophobic and hydrophilic environments, respectively.40 The
anisotropy of each hydrogel was calculated for both the hydrophobic and hydrophilic
wavelengths in order to determine the restriction of ANS rotation in the hydrophobic gel
fibers and the aqueous pools (Figure 2.3). Higher anisotropy values in a hydrophobic
environment suggest higher rigidity of gel fibers, and higher anisotropy values in a
hydrophilic environment indicate a smaller water pool between the fibers. This
rationalization is the result of both a more rigid network and a smaller water pool each
decreasing the free rotation of a fluorophore, thereby increasing anisotropy.
Anisotropy studies at 430 nm aid in examining the rigidity of the hydrogel fibers,
where an increase in anisotropy indicates an increase in rigidity. The anisotropy, and
therefore rigidity, within the fibrous network of pH 5.5 hydrogel was found to increase
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with increasing TRIS concentration from -0.23 in the 25 mM TRIS hydrogel to 0.057 in
the 500 mM TRIS hydrogel. The rigidity of the pH 6.8 gel fibers was also found to
increase with TRIS concentration with an anisotropy increase from -0.11 to 0.11 from
the hydrogel with 25 mM TRIS to that with 500 mM TRIS. However, hydrogel fibers at
the physiological pH value of 7.4 were observed to produce no significant change in
rigidity with varying TRIS concentration, while exhibiting an average anisotropy of 0.028
± 0.004. Except at pH 7.4, an increase in TRIS concentration resulted in an increase in
hydrogel fiber rigidity.
The sizes of the aqueous pools within the hydrogel network were estimated from
the anisotropy values at 530 nm. A smaller anisotropy indicated greater rotational
diffusion of the excited state of the fluorophore and therefore larger pool sizes.
Examination of these results suggested that the size of the aqueous pools within the pH
5.5 hydrogels increased at lower TRIS concentrations and decreased at higher TRIS
concentrations. The 25 mM TRIS and 100 mM TRIS hydrogels exhibited anisotropies of
-0.058 and -0.029 respectively at the hydrophilic wavelength of ANS. From 200 to 500
mM TRIS, the anisotropy was found to decrease from -0.033 to -.075. The size of the
aqueous pools within the hydrogel network at pH 6.8 was found to increase with TRIS
concentrations. The anisotropy values decreased from 0.10 to 0.062 with increasing
TRIS concentration from 25 mM to 500 mM. At a pH value of 7.4 with 25, 100, and 200
mM TRIS, anisotropy of ANS in the aqueous pools of the hydrogels had an average
value of 0.021 ± 0.008. The higher concentrations of 300 and 500 mM TRIS resulted in
larger pool size with an average anisotropy of -0.014 with insignificant deviation. In
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general, an increase in TRIS concentration resulted in formation of larger water pools
after gelation.
A)

B)

Figure 2.3. Calculated anisotropies at A) hydrophobic wavelength (430 nm) and B)
hydrophilic wavelength (520 nm).
2.3.3. Polarized optical microscopy (POM) of modified hydrogels
The morphology and crystallinity of these hydrogels were characterized by use of
POM, which is often employed for studies of birefringent materials. This characterization
yields important information for potential applications of the materials. For example,
morphology and crystallinity may impact thermal stability, ability to form tough materials,
use in sensing applications, and use in soft electronics. Figure 2.4 is a compilation of
polarized optical micrographs of hydrogels at pH 5.5, 6.8, and 7.4 with increasing
concentrations of TRIS. Hydrogels of pH 5.5 with 25 mM and 200 mM TRIS exhibited
fibrous structures, while hydrogels with 500 mM TRIS displayed spherulite crystalline
domains. The increased rigidity of the hydrogels and the appearance of spherulite like
microstructures at higher TRIS concentrations may be attributed to increased
crystallinity of the modified hydrogels. This increased crystallinity with increasing TRIS
concentration was found within each pH level studied. By increasing the TRIS
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concentration, the concentrations of structured hydrogen bond donors and acceptors
also increased, producing more stability and alignment for the hydrogel network.

Figure 2.4. POM micrographs of pH 5.5, 6.8, and 7.4 hydrogels each with 25, 200, and
500 mM TRIS. Crystallinity is represented by brightness, and domains were found to be
amorphous, fibrous, or spherulite in morphology. At pH 6.8 25 and 200 mM and pH 7.4
25 mM the micrographs were completely black with no apparent crystallinity.
2.3.4. XRD studies
X-ray diffraction (XRD) studies in conjunction with circular dichroism and quasielastic light scattering have been previously used to show that the structure and
arrangement of NaDC molecules depend on several conditions including concentration,
temperature, and salt concentration.38,41 These studies showed that deoxycholate
aggregates in cylindrical, helical, or spherical patterns are strongly induced as a result
of hydrogen bonding. XRD studies were performed on hydrogels with 25, 200, and 500
mM TRIS at each of the three pH values (Figure 2.5) in order to quantify the crystallinity
of these modified hydrogel structures. Counts obtained through XRD measurements
have a direct relationship to crystallinity: Higher counts indicate higher crystallinity.
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Examination of data from these studies confirmed that, in general, the crystallinity of the
hydrogel increased with TRIS concentration, as visualized using POM.
For a pH value of 5.5, 25 mM TRIS produced a fairly amorphous hydrogel lacking
any significant crystalline domains. Evaluation of the 200 mM TRIS hydrogel showed
relatively intense crystalline planes at 2θ = 10.86° (5877 counts) and 21.7° (4594
counts). Peaks at these angles correspond to short range spacings of 8.3 and 4.1 nm,
respectively. The 500 mM hydrogel exhibited several less intense (by an order of
magnitude, ranging between 100 and 600 counts) crystalline planes between 2θ = 40°
and 70°.
At pH 6.8, hydrogels with 25 and 200 mM TRIS had similar planes of crystallinity
each at 2θ ≈ 10.7° and 21.5° with about 3300 and 2000 intensity counts, respectively.
The intensities of these peaks were increased in the 500 mM hydrogel (13000 and
14400 counts respectively), where several less intense planes also resulted.
The XRD profile of the 25 mM gel at pH 7.4 revealed an amorphous hydrogel.
This result is closely aligned with the liquid-like appearance of the hydrogel. The 200
and 500 mM hydrogels again showed peaks at 2θ ≈ 10.8° and 21.7°, although the
intensities do not follow the trend observed at other pH values. The intensities of the
peaks exhibited by the 200 mM hydrogel (27000 and 24000 counts at 10.8° and 21.7°,
respectively) were about twice as intense as those exhibited by the 500 mM hydrogel
(about 13000 and 9700 counts at 10.8° and 21.7°, respectively). A pH of 7.4 is well
above the pKa of NaDC (6.6), resulting in charged, less hydrophobic molecules. This is
expected to reduce the hydrogen bonding interactions as well as the hydrophobic
interactions. It is evident from these results that hydrogen bonding is an extremely
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important factor for increased gel rigidity. Based on these results, it follows that
hydrogels with different planes of crystallinity should provide different templates for
nanoparticle synthesis and thus can be exploited for such applications.
B

A

Figure 2.5. X-ray diffraction patterns of A) 25 mM TRIS and B) 500 mM TRIS, where
increased counts indicate increased crystallinity.
2.3.5. DSC studies
Sol-gel transitions are endothermic events and can, therefore, be measured
using DSC.42 Endothermic transitions are represented by a significant decrease in
measured heat flow. The sol-gel temperature of this system was found to increase with
TRIS concentration, which is considered the result of increased crystallinity and network
stability.43 In this study, the sol-gel transition temperatures of the hydrogels were tuned
from about 35 °C to about 65 °C (Table 2.2). Such a property could be extremely useful
for in situ applications in that a hydrogel system could be selected to undergo or to
avoid a sol-gel transition during an experiment. For example, a sol-gel temperature
above 37 °C would allow a hydrogel to be used in vivo as artificial tissue or an
implantable drug delivery device.44
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Table 2.2. Sol-gel transition temperatures of gels as measured by differential scanning
calorimetry. (Note: Due to the high water content and lack of covalent bonding, specific
protocols were developed for each sample. An appropriate methodology could not be
found for DSC analysis of these (*,**) gels. However, a sol-gel transition was visually
observed between 50 and 60 °C for each of the three * samples and slightly above
room temperature for the single ** sample.)

pH 5.5

pH 6.8

pH 7.4

concentration (mM)

approximate sol-gel
temperature (°C)

25
100
200
250
300

37
49
*
*
*

500
50
100
200

63
36
47
51

400
25
100
200
300
500

54
**
50
51
61
57

Measurements provided by use of DSC were also confirmed by visual
observations of the gels in a water bath of gradually increasing temperature. An
approximate temperature was recorded when a sample no longer appeared to have a
gelatinous consistency. For example, the visually observed sol-gel temperature for pH
6.8, 50 mM (as seen in Table 2.2) was about 35 °C, compared to the DSC
measurement of 36 °C (Figure 2.6). Increased sol-gel temperature with increased TRIS
concentration confirmed the XRD and POM findings of increased crystallinity and rigidity
under such conditions.
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Figure 2.6. DSC thermogram of a hydrogel of pH 6.8 and 50 mM TRIS. The sharp
decrease at 36 °C indicates a sol-gel transition. This closely corresponds to a visually
observed transition at approximately 35 °C.
2.3.6. Rheology
Rheological studies are typically performed in order to examine the viscoelasticity
of hydrogels.45 Such studies are important for understanding the utility of these gels for
various applications. For instance, high mechanical strength hydrogels can be useful for
materials applications.46 The storage modulus (G’) and the loss modulus (G”) were
determined for each sample as a function of angular frequency (rad/s). Each hydrogel of
this study had a particular shear rate after which the G’ and G” showed erratic behavior.
This is the shear rate at which there is enough mechanical stress placed on the
structure of the gel such that it began to have greatly increased fluidity. This is
commonly referred to as “breaking” the gel.47 For pH values of 6.8 and 7.4, both the G’
and G” showed a break at shear rates that increased with increasing concentrations of
TRIS. This further supports the theory that increasing the TRIS concentration increases
the internal structural rigidity of the hydrogels. At pH 5.5, the G” follows the observed
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trend as well, with the breaking rate increasing from 28.6 rad s-1 to > 63 rad s-1 when the
TRIS concentration increases from 25 to 500 mM. However, the G’ does not follow an
observable trend, which suggests a more complicated gelation mechanism. This
observation is also complementary to fluorescence anisotropy results for the
hydrophobic gel fibers where no regular trend was observed at this pH. The increase in
fluidity that occurs during breaking lends to potential use of these hydrogels as drug
delivery systems.48 In addition, gels with high rigidity have potential utility for use in
biotechnology applications such as artificial tissues.49
Under shear stress, a unique behavior was observed in several of the hydrogels
in this study, namely pH 5.5: 200, 250, and 300 mM TRIS; pH 6.8: 200 mM TRIS; and
pH 7.4: 300 mM TRIS (Figure 2.7 A-E). A plot of storage modulus versus shear
frequency yielded two stable regions as opposed to the generally observed single
region. In cases where no data are shown between the two stable regions (Figure 2.7 B,
C, and E), the G’ exhibits an erratic behavior indicative of a broken gel in the omitted
region. Presence of two stable regions in the elastic modulus indicated that there are
two ranges of shear frequency in which the hydrogels form stable structures. To the
best of our knowledge, such a behavior has not been previously observed and yields
exceptional potential for applications in injectable drug delivery.50,51 Preliminary work
was done to investigate this potential, and both hydrogel formulation and shearing seem
to significantly affect drug release (Figure 2.7 F), warranting further investigation.

2.3.7. Characterization of hydrogel-templated nanoGUMBOS and microGUMBOS.
Modifications to the NaDC hydrogels, including changes in TRIS concentration
and pH, led to tunable size variations of nano- and microGUMBOS formed therein
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(Table 2.3). All nano- and microGUMBOS in this study are NIR dyes with potential
applications in biological imaging. NanoGUMBOS formed in pH 5.5 hydrogel templates
were relatively consistent in size at low TRIS concentrations with no specific trend
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Figure 2.7. A-E: Rheograms (G’) showing two distinct hydrogel structures at different
ranges of shear rates. A) pH 5.5, 200 mM TRIS; B) pH 5.5, 250 mM TRIS; C) pH 5.5,
300 mM TRIS; D) pH 6.8, 200 mM TRIS; and E) pH 7.4, 300 mM TRIS. F: Release of
fluorescein from several formulations. The green bars correspond to release from gels
that had not been sheared and the blue to release from gels that had been sheared to
45 rad/s.
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Table 2.3. Average size of [HMT][NTf2] nano- and microGUMBOS as measured from
TEM micrographs.
[TRIS]
pH

size (nm)
(mM)
25

57 ± 6

100

46 ± 8

200

44 ± 8

250

72 ± 14

300

809 ± 150

500

8±1

25

76 ± 6

200

48 ± 11

300

21 ± 4

500

19 ± 4

50

33 ± 9

100

62 ± 29

200

209 ± 35

400

30 ± 4

25

154 ± 26

100

221 ± 58

300

312 ± 58

5.5

6

6.8

7.4

observed with increasing TRIS concentration. For example, the size of [HMT][NTf2]
remained almost constant at 50 nm with increasing TRIS concentration between 25 and
200 mM. At 250 mM TRIS, such nanoGUMBOS slightly increased in size to 72 ± 14 nm
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with even greater increases at 300 mM TRIS (microGUMBOS of 809 ± 150 nm).
Additional increases in TRIS concentration to 500 mM led to a significant decrease in
size of the nanoparticles to 8 ± 1 nm.
Hydrogels immobilized at pH 6.0 with 25 mM TRIS yielded [HMT][NTf2]
nanoparticles with an average size of 76 ± 6 nm (Figure 2.8A). This is effectively the
same size as nanoparticles produced under similar conditions with the GUMBOS
[HMT][AOT].7 TRIS concentrations of 200 mM, 300 mM, and 500 mM resulted in
respective particle sizes of 48 ± 11, 21 ± 4 nm, and 19 ± 4 nm (Figure 2.8 B-D). The
size of the [HMT][NTf2] nanoparticles were found to decrease with increasing TRIS
concentration. This trend was the reverse of that found with [HMT][AOT] studies where
particle size was found to increase with TRIS concentration.
A)

B)

C)

D)

Figure 2.8. TEM micrographs of [HMT][NTf2] nanoGUMBOS as templated by pH 6
hydrogels with A) 25 mM TRIS, B) 200 mM TRIS, C) 300 mM TRIS, and D) 500 mM
TRIS. Under these conditions, particle size decreases with increasing TRIS
concentration.
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Contrasting trends found in nanoGUMBOS with [NTf2] and [AOT] anions is
believed to be a result of the relative hydrophobicities as determined by octanol/water
partition coefficients (Poct/wat). Hydrophobicity of [NTf2] is significantly greater than that of
[AOT] with respective koct/wat values of 14.8 and 1.65. NanoGUMBOS with an even
greater hydrophobicity (koct/wat=29.9), [HMT][TPB], were templated in pH 6.0 gels to
confirm this theory. While the [HMT][TPB] nanoGUMBOS increased in size with an
increase in TRIS, the particles had a wider range in size than did either of the other two
GUMBOS investigated. From 25 to 500 mM TRIS, the [HMT][TPB] particles increased
from 3.6 ± 0.5 to 257 ± 56 nm, indicating that particle size is material-dependent.
However for a given material a definite trend in size was observed suggesting the
applicability of these modified hydrogel systems for size-controlled synthesis of
nanoparticles.
While the [HMT][NTf2] nano- and microGUMBOS resulting from pH 6.8 templates
did not follow an obvious trend in size, the sizes are consistent with the anisotropy
studies performed on these gels. In smaller aqueous pools such as with 50 mM and 400
mM TRIS, the particles were 33 ± 9 nm and 30 ± 4 nm respectively. The largest
aqueous pool of this pH formed the largest particles, i.e. 200 mM TRIS hydrogel forming
209 ± 35 nm particles. Pools of intermediate size, found in the 100 mM TRIS hydrogel,
templated nanoGUMBOS of an intermediate size, i.e 62 ± 29 nm. This again suggests
that the size of the aqueous pools is one of the governing factors for size control of the
templated nanoparticles.
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At pH 7.4, most particles were significantly larger than at other pH values and
generally increased in size with increasing TRIS concentration from 154 ± 26 nm to 312
± 58 nm with TRIS concentrations of 25-300 mM.
2.4.

Conclusions
In conclusion, I have developed multiple new NaDC/TRIS hydrogel materials

through variation of TRIS concentration within fixed pH values. These new materials
were characterized and evaluated for nanosynthesis and drug delivery applications.
Modification of the hydrogels led to a broad range of attainable properties.
NanoGUMBOS of three NIR dyes were templated using hydrogels, and the resulting
nanoparticle size was concluded to be material dependent and governed by the gel
microstructure and rheological characteristics. As evidenced by anisotropy calculations,
POM, and XRD characterization, pH and TRIS concentration within a given pH play an
extremely important role towards crystallinity and structural rigidity of the hydrogels.
Tunable crystallinity resulted in tunable sol-gel transition temperatures between slightly
above room temperature and 63 °C, as measured by DSC and visually observed.
Rheological studies showed that these designer hydrogels have tunable mechanical
properties that could be suitable for bioengineering and drug delivery applications.
Tunability was found in hydrogels immobilized at the physiological pH value, further
demonstrating suitability in biological applications.
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CHAPTER 3.
SODIUM DEOXYCHOLATE/TRIS-BASED HYDROGELS FOR
MULTIPURPOSE SOLUTE DELIVERY VEHICLES: AMBIENT RELEASE,
DRUG RELEASE, AND ENANTIOPREFERENTIAL RELEASE*
3.1. Introduction
The study of controlled and sustained drug release vehicles has been a topic of
increasing attention over the past several decades. Delivery vehicles are widely applied
in many fields ranging from food production to agriculture to pharmaceuticals.1 Drug
delivery vehicles, specifically, are rapidly gaining importance as the focus of drug
development shifts from small molecules to macromolecular biologics.2 Biologics require
higher delivery concentrations,3 more protection from metabolic interactions,4 and more
targeted delivery than small molecule drugs.5 Due to these requirements, more
sophisticated delivery vehicles are needed. Hydrogels are often selected as drug
delivery vehicles because of similarities to biological membranes6 and beneficial
characteristics7

including

high

water

content

relative

to

other

materials,8

biocompatibility,9 biodegradability,10 stimuli-responsiveness,11 and high porosity.12 Low
molecular weight (LMW), physical hydrogels have the benefits of facile processing13 and
lower toxicity due to the absence of crosslinkers.14
Hydrophobic domains within a hydrogel network can be used to increase

* This chapter previously appeared as “McNeel, K. E., Siraj, N., Negulescu, I., &
Warner, I. M. Sodium deoxycholate/TRIS-based hydrogels for multipurpose solute
delivery vehicles: Ambient release, drug release, and enantiopreferential
release.” Reproduced with permission from Talanta. 177, 66-73. Copyright 2017
Elsevier B.V.
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loadable drug concentration because most pharmaceuticals have low water
solubility.7,15,16 Hydrogel matrices are often used to protect drugs, specifically biologics
such as proteins and antibodies, until the target is reached.4 Injectable hydrogels are
also often used for biologics to provide more targeted delivery. Protection of drugs also
lowers the necessary dosage by reducing dilution of the drug in the body and retaining
elevated local concentration through slow release.7 Furthermore, frequency of
administration can be reduced through the use of a hydrogel exhibiting sustained
release properties.17
In addition to the rising number of biologic drugs, more than half of the molecular
drugs on the market are chiral and exist as a mixture of enantiomers, making chirality
an important consideration in the pharmaceutical industry.18 In many cases, one
enantiomer is less active than the other, making separation of enantiomers beneficial. In
more severe cases, one enantiomer exhibits toxicity, which highlights the importance of
enantiomeric separations. In order to formulate a pharmaceutical with a single
enantiomer, a separation method such as chromatography or capillary electrophoresis
is

typically

employed.19,20,21

When

these

traditional

methods

of

separations

(chromatography, electrophoresis) are employed, enantiomeric separation must occur
offline before the separated drug can be administered, thereby increasing cost and time
for pre-processing. An ideal solution would involve racemic drug loading (i.e. equal
amounts of each enantiomer) into a delivery vehicle from which only one enantiomer
would be released.22 Over the past decade, a few enantio-selective release hydrogels
have been designed using a variety of methods and polymeric or LMW gelators. For
example, Suedee et al. reported on chitosan-based transdermal patches for selective
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delivery of S-propranolol.23 This group later developed a pH-responsive system
composed of poly(hydroxyethyl methacrylate) and polycaprolactone-triol for selective
delivery of S-omeprazole.24 In 2014, Suksuwan et al. demonstrated selective release of
R-thalidomide from a polymer network composed of methacrylic acid, 2,6bis(acrylamido)pyridine, and N,N’ methylene-bis-acrylamide.25 All three of these
systems have excellent functionality in delivering the desired enantiomer. However, in
all cases, synthesis of such systems required many steps, inclusive of chemical
modification, polymerization, and molecular imprinting. Each of these steps takes
technical ability and significant analysis, increasing the time and cost of development
and production.
The Warner research group has recently studied the tunability of sodium
deoxycholate (NaDC)/ tris(hydroxymethyl)aminomethane (TRIS) hydrogel systems.26,27
Mechanical properties, sol-gel temperature, and release propeties were found to be
tunable with modifications to pH and TRIS concentration. In the current study, I extend
the preliminary findings of the previous work to explore the drug delivery capabilities of
NaDC/TRIS hydrogels using model drugs of variable molecular weight and chirality.
Analytes include fluorescein (a small molecule), bovine serum albumin (a 66 kDa
protein), and the chiral molecules tryptophan and ibuprofen. The effect of shearing on
the release of solutes was examined in order to simulate injection, as in subcutaneous
drug delivery. Furthermore, other variables such as temperature, drug concentration,
and hydrogel formulation were also explored as parameters affecting drug release.
Each of these variables can be varied to tune drug release, indicating the broad
tunability of NaDC/TRIS hydrogels as solute delivery systems. The specific application
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of enantio-preferential drug release was examined in detail through release of both
enantiomeric forms of model drugs. This NaDC/TRIS hydrogel system is a facilely
synthesized, inexpensive candidate for injectable and enantio-selective drug delivery.
3.2. Materials and methods
3.2.1. Materials
Sodium deoxycholate (NaDC) (≥ 97%), tris(hydroxymethyl)aminomethane (TRIS)
(≥ 99.9%), fluorescein sodium salt (≥ 97.5%), bovine serum albumin (BSA) (≥ 96%), αlactalbumin (αLB) (≥ 85%), (S)-(+)-ibuprofen (≥ 99%), L-phenylalanine (≥ 98%), and Ltryptophan (≥ 98%) were purchased from Sigma Aldrich. (R)-(-)-ibuprofen (≥ 98%) was
obtained from Enzo Life Sciences. D-phenylalanine (≥ 99.9%) and D-tryptophan (≥ 98%)
were obtained from Bachem. γ-Cyclodextrin (≥ 98%) was obtained from Fluka. All
chemicals were used as received. Triply deionized water (18 MΩ cm) was obtained from
an Aries Filterworks high purity water system and used for all experiments.
3.2.2. Hydrogel selection and synthesis
Aqueous TRIS buffer solutions were prepared at 200, 250, and 300 mM. By use
of hydrochloric acid, each TRIS solution was adjusted from an initial native pH value
greater than 10 to an acidic pH value of 5.5. Solutions of 200 mM TRIS were also
adjusted to a pH value of 6.8, generating a total of four formulations. These conditions
of pH value and TRIS concentration were chosen because they were previously found
to yield interesting rheological properties.27 NaDC was added to the TRIS buffer
solutions as a solid to produce a final concentration of 20 mM. NaDC addition was
followed immediately with 30 seconds of vortexing and 20 minutes of bath sonication.
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After sonication, samples were left to stabilize at 5 °C overnight before analyses. For
drug delivery applications, it is useful to note that gelator is less than 1% of the system
by weight. The hydrogel is composed of a maximum 6% TRIS (at 500 mM), while the
remaining ≥ 93% is water.
3.2.3. Swelling Measurements
Swelling ratio is an important characteristic of hydrogel drug delivery vehicles
due to drug loading and in vivo behavior dependence on these values. In order to
measure swelling ratios, hydrogels were synthesized as previously outlined. Excess
water was added to each gel after overnight stabilization, and samples were left to
equilibrate for a week. After one week, any excess water not immobilized by the
hydrogel was removed (leaving ms). Dried gels were obtained by leaving exposed
hydrogel samples in a desiccator (md). Swelling ratio was calculated as follows:

where ms is the mass of the swollen hydrogel and md is the mass of the dry sample.
3.2.4. Viscoelastic measurements
A TA AR 1000 rheometer (TA Instruments, Inc., Waters Corp., New Castle, DE)
with stainless steel plate geometry was used to investigate the rheological properties of
these hydrogels, specifically the G’ and G” moduli. This rheometer was also used to
shear the hydrogels before solute release analyses.
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3.2.5. Solute release measurements
Solute release measurements were performed using sets of identical hydrogels
to measure different parameters within the same experiment. For example, if solute
release was measured after one hour and after six hours, two hydrogels were prepared
(one for each time of interest). At fixed time intervals, drug release was monitored by
use of the absorbance of the supernatant. Absorbance was measured using a UV-visnear-IR scanning spectrometer (Shimadzu, Columbia, MD). A 4 mm path length quartz
cuvette (Starna Cells) was used for absorbance measurements with an identical cuvette
filled with phosphate buffer as a blank. Fluorescein concentration was calculated using
a linear calibration curve. Model drugs based on proteins and amino acids (BSA, αlactalbumin, tryptophan) were analyzed at the absorbance wavelength of 280 nm.
Ibuprofen was analyzed at 210 nm. Release experiments were performed at two
different temperatures as noted with the corresponding data. All tryptophan and
ibuprofen release experiments were performed at 37 °C. Room temperature
experiments were performed under purely benchtop conditions. Experiments at 37 °C
were performed in a temperature controlled incubator.
3.3. Results and discussion
3.3.1. Swelling capacity of hydrogels
Diffusion of drugs and other solutes from a hydrogel network is due in large part
to the swelling capacity of the hydrogel system. Generally, an increased swelling ratio
results in increased drug release. In the case of NaDC/TRIS-based hydrogels, swelling
ratio was found to be dependent on TRIS concentration of hydrogel formulation (Table
3.1). Interestingly, the calculated swelling ratio decreased with increasing TRIS
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concentration at pH 5.5. Hydrogels of pH 5.5, 200 mM TRIS had swelling ratios of 72.9
± 0.9. An increase in TRIS concentration to 250 mM at pH 5.5 resulted in a significantly
decreased swelling ratio of 57.0 ± 0.4. A further increase in TRIS concentration (i.e. to
300 mM) resulted in a smaller decrease in swelling ratio to 50.6 ± 0.2. Since TRIS has
hydrogen bonding sites, it is likely that increased TRIS concentration reduced swelling
by physically crosslinking the hydrogel to a further degree at higher concentrations.
Previous work has also shown that this increase in [TRIS] enhanced the crystallinity,
further supporting that increased [TRIS] restricted the hydrogel swelling.
Table 3.1. Swelling ratio of hydrogels with varied TRIS concentration

[TRIS] (mM)

Swelling ratio

200

72.9 ± 0.9

250

57.0 ± 0.4

300

50.6 ± 0.2

3.3.2. Viscoelasticity of solute-loaded hydrogels
I previously reported that several formulations of NaDC/TRIS-based hydrogels
exhibit a unique rheological behavior.27 The elastic modulus (G’) of these materials
showed two stable regions instead of the typical single region. The presence of two
stable regions is interpreted as a rearrangement of internal gel structure upon
application of sufficient shear rate.
Sun and colleagues28 observed that the addition of certain amino acids to sodium
deoxycholate hydrogels would disturb the hydrogel network enough to induce a gel-to74

sol transition. Since many target molecules for injectable systems are composed of
proteins, it is of the utmost importance that this system retains its viscoelasticity upon
addition of proteins. Figure 3.1A shows the elastic moduli of hydrogels of pH 5.5, 300
mM TRIS with 0, 1, 10, and 50 mg/mL BSA. As shown in this figure, increases in BSA
concentrations (from 0-50 mg of BSA per mL of hydrogel) did not significantly change
the observed elastic modulus of hydrogels within the range of angular shearing
frequencies examined. It is important to note that the presence of two stable elastic
regions is retained at all protein concentrations examined. The retention of viscoelastic
properties with addition of BSA indicated that these hydrogels are good candidates for
protein delivery systems.
B
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Figure 3.1. Angular frequency vs. G’, storage modulus, of hydrogels pH 5.5 and 300
mM TRIS A) Four concentrations of BSA, i.e. 0, 1, 10, and 50 mg/mL. B) 3 proteins
loaded at 10 mg/mL.
Three proteins of varying sizes were loaded into hydrogels of pH 5.5, 300 mM at
10 mg/mL (viz. cytochrome c – 12 kDa, α-chymotrypsinogen – 25.6 kDa, transferrin –
80 kDa). The elastic moduli of these protein-loaded gels were not significantly different
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from those of native (i.e. non-loaded) hydrogels (Figure 3.1B). The unchanged moduli
suggest that the hydrogel structure is highly resilient and can be used with a wide
variety of loaded protein drugs.
3.3.3. Fluorescein release: effect of shearing, hydrogel formulation, loaded
concentration, and temperature
Small molecule solutes, such as dyes, are often desirable for sustained release
applications. The release of a small solute, fluorescein, was examined from sheared
and non-sheared hydrogels of pH 5.5, 300 mM TRIS at room temperature and at 37 °C
in order to analyze utility of this hydrogel system as a drug delivery vehicle (Figure 3.2).
At room temperature, sheared and native gels completed fluorescein release in
approximately 6 hours. Shearing resulted in a significant increase of total fluorescein
released. Maximum release of fluorescein was increased from 175 µM to 303 µM, i.e.
almost double. Disodium salt of fluorescein has significant water solubility. It is likely
that upon shearing, the hydrogel structure becomes more porous in such a manner that
fluorescein diffuses out in greater quantity. This significant increase in fluorescein
release is critical to applicability of this system. To the best of our knowledge, this
shearing effect on solute release has not been previously explored. The significant
difference in release indicates that the mode of application (i.e. whether or not the
hydrogel will be sheared before desired release) must be taken into consideration when
calculating solute loading versus solute dosing concentrations for ambient temperature
release.
Release of fluorescein at 37 °C was similarly found to plateau in ~6 hours (Figure
3.2B). Samples were allowed to release for 18 hours in order to ensure complete
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Figure 3.2. Release profiles of 500 µM disodium fluorescein from pH 5.5, 300 mM TRIS
hydrogels that had and had not been sheared. A) Release at room temperature B)
Release at 37 °C
release. Within the first hour, sheared hydrogels released significantly more fluorescein
than a hydrogel that had not been sheared. As seen with room temperature release,
shearing likely disrupted the crystalline packing of the hydrogel structure, which
consequently lessened the hindrance of fluorescein release. At later time intervals, the
difference was no longer as significant. However, within a single trial, sheared release
was always higher than non-sheared release. Over longer periods of time at 37 °C,
crystallinity of hydrogel structure likely began to reform (i.e. self-repair) from the
disruption of shearing as evidenced by similarity in released fluorescein from sheared
and non-sheared hydrogels at later times. The majority of release occurred within the
first three hours, indicating that these materials are not suitable for prolonged release (>
6 hours) in their current form. For release over shorter time periods (< 6 hours) the
mode of application (sheared or not) should still be considered. Long-term release
applications can be loaded with less consideration of application mode for release at 37
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°C. Thus, final solute release must be determined based on whether or not a shearing
force will be applied to the gel before desired release and the temperature at which
release will occur.
Three hydrogel formulations were investigated as sustained release vehicles.
Specifically, solutions immobilized at a pH value of 5.5 were evaluated with three
different TRIS concentrations, viz. 200 mM, 250 mM, and 300 mM. Increases in TRIS
concentration has been previously shown to increase crystallinity of the materials, which
may itself impact release.26,27 As expected, formulation was determined to significantly
affect total fluorescein release at room temperature (Figure 3.3A). It was found that at
pH 5.5, an increase in TRIS concentration decreased the total amount of fluorescein
released from hydrogels that had not been sheared. This decrease closely followed the
decreased swelling ratio found between these hydrogel formulations. The decrease in
fluorescein release also suggested that the closely related parameter of crystallinity
impeded solute release. Interestingly, it was found that increased TRIS concentration
also resulted in an increase of total fluorescein released from hydrogels that had been
sheared. It is possible that shearing disrupted the crystalline packing of these materials,
thereby reducing the impediment on solute release. Interestingly, at 37 °C average
release of fluorescein decreased with increasing TRIS concentration (Figure 3.3B). As
was seen at room temperature, decreased fluorescein release from gels that had not
been sheared paralleled the decrease in swelling ratio. Unlike at room temperature, this
trend was seen in both gels that had and had not been sheared. The decrease in
amount of fluorescein released was likely due in part to crystallinity of the samples.
While shearing is thought to disrupt crystallinity in these materials, examination of these
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data suggested that at 37 °C, hydrogels reformed crystalline packing. Therefore, the
amount of solute released from a hydrogel could be tuned simply by changing TRIS
concentration when the mode (sheared or not) and temperature of delivery are known.
The ease of this tunability is exceptionally useful for the applicability of this system.
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Figure 3.3. Effect of TRIS concentration in pH 5.5 hydrogels on release of fluorescein at
A) room temperature B) 37 °C.
Several concentrations (viz. 100, 300, 500, 700, and 1000 μM) of fluorescein
were loaded into hydrogels of pH 5.5, 300 mM. Total release at 37 °C was measured
via absorbance after the plateau of release. A linear correlation was found between an
increase in the concentration of fluorescein loaded and an increase in fluorescein
released (Figure 3.4). Final concentration released was found to increase from 48.02 ±
18.03 μM (non-sheared) and 69.88 ± 32.29 μM (sheared) in gels loaded with 100 μM
fluorescein to 458.00 ± 32.14 μM (non-sheared) and 449.30 ± 20.15 μM (sheared) in
gels loaded with 1000 μM fluorescein with a linear correlation of R2 = 0.98. This linear
correlation is incredibly useful for solute delivery applications because it enables the
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necessary loading concentration to easily be calculated when the required dosage is
known.
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Figure 3.4. Total release of fluorescein from pH 5.5, 300 mM TRIS hydrogels at 37 °C
when loaded with 100-1000 μM fluorescein.
3.3.4. BSA release: effect of shearing, hydrogel formulation, loaded
concentration and temperature
Large molecules, often proteins and other biologics, are also useful as released
agents from hydrogels. In order to examine the release of proteins, BSA –a protein of
66 kDa– was chosen as a large model solute. At room temperature, shearing of the
hydrogel material had the opposite effect on this large solute than on the small solute
fluorescein (Figure 3.5). At shorter time intervals (< 6 hours), BSA was released less
from gels that had been sheared than from gels that had not been sheared. At longer
time intervals (24-72 hours), there was no longer a significant difference in BSA release
from sheared and non-sheared hydrogels. NaDC/TRIS hydrogels are formed primarily
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through hydrophobic interactions and hydrogen bonding. This hydrogel formulation
employed an acidic solution (pH 5.5) which may slightly denature BSA. Since BSA has
many hydrophobic domains and hydrogen bond donors and acceptors, it is possible that
applying a shear force to the gel may have increased protein/hydrogel interaction
density. Shearing therefore inhibited initial release of BSA. Similarity of release at longer
time intervals further supported the theory that the hydrogel network self-repairs after
shearing.
Pharmaceutically relevant concentrations of protein-based drugs are typically
between 10 and 100 mg of protein per mL of delivery matrix. For many hydrogel
delivery systems, loading such a high concentration of protein is not feasible because
drug loading is done through sorption or because such concentrations lead to a reversal
of gelation. In the case of this NaDC/TRIS hydrogel system, solute loading occurs
concurrently with gelation. Thus, protein is added to the buffer solution before gelator is
added and before gelation begins. The result of this concurrent gelation is that high
concentrations of protein can be added without disruption of the hydrogel structure. This
high loading is of paramount importance to the true applicability of a hydrogel delivery
system.
BSA was loaded to 50 mg/mL for examination of its release at 37 °C. It was
found that at many time intervals, BSA was released more from gels that had been
sheared than from gels that had not been sheared (Figure 3.7). However, at 24 and 72
hours, the release is not significantly different. At room temperature, shearing was found
to decrease BSA release. Shearing increased release of BSA at 37 °C, indicating that
increased temperature weakened hydrogen bonding sufficiently for BSA release to be
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increased. Increased release was due to a more porous hydrogel network as seen in
fluorescein release. However, the convergence of release profiles at 24 and 72 hours
showed that release was controlled by multiple factors. Reforming of the hydrogel
network apparently incorporated some the released BSA back into the hydrogel network
(see decreased total release at 24 hours). It can be concluded that the type of hydrogel
application (sheared or non-sheared) and the desired time of release should be
considered when calculating loading and dosing concentrations for this set of
conditions.
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Figure 3.5. Release profiles of BSA from pH 5.5, 300 mM TRIS hydrogels that had and
had not been sheared A) Room temperature release (loaded to 1.3 mg/mL) B) 37°C
release (loaded to 50 mg/mL).
Three formulations of NaDC/TRIS hydrogels were examined in order to analyze
the effect of modification on the release of BSA at room temperature (Figure 3.6A) and
at 37 °C (Figure 3.6B). In the case of hydrogels of pH 5.5 with 200 mM TRIS, shearing
significantly lowered the amount of BSA released at room temperature. This lower
concentration of TRIS resulted in more hydrogen bonding sites for BSA, resulting in
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increased effect of shearing. However, hydrogels of pH 5.5 with 250 mM and 300 mM
TRIS did not yield a significant difference in BSA release from gels that had and had not
been sheared. There is not a direct relationship between BSA released at room
temperature and TRIS concentration. Hydrophobic domains and hydrogen bonding sites
of BSA interacted with the hydrogel network resulting in a complex release mechanism.
Therefore, hydrogel formulation and mode of application must both be considered
before calculating solute loading concentrations of large molecules. Tunability of
hydrogel formulation may still be utilized in cases where total release is not significantly
affected. For example, the mechanical strength of a hydrogel of pH 5.5, 300 mM TRIS
may be required for a specific application, while the final release of a pH 5.5, 200 mM
TRIS hydrogel is known to be appropriate. In this case, hydrogel formulation can be
altered without significantly changing solute release. Thus, the tunability in hydrogel
properties, including amount of drug release and sol-gel temperature, can be used to
design a hydrogel system which is well-suited to a particular application.
The total amount of BSA released at 37 °C was consistent between formulations
and between gels that had and had not been sheared within a formulation. Thus, it is
likely that BSA released at 37 °C was primarily diffusion controlled at long time intervals.
This consistency in release can be very desirable for clinical application because
hydrogel formulation can then be used to tune other properties of the hydrogel (e.g.
mechanical strength) without significant impact to drug loading calculations.
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Figure 3.6. Comparison of BSA release from three hydrogel formulations that had and
had not been sheared at A) room temperature and B) 37 °C.
Although pharmaceutically relevant concentrations of protein-based drugs are
typically between 10-100 mg/mL, sustained release applications for food and agriculture
often have substantially lower concentration requirements. For this reason, release
profiles at three different concentrations of loaded BSA were examined (Figure 3.7). As
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Figure 3.7. Effect of loaded BSA concentration on total release at 37 °C.
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was determined with fluorescein, final release of BSA was found to increase with
concentration of BSA loaded into the gel. BSA is known to be water soluble up to 40
mg/mL. A similar proportionality between concentration of solute loaded and amount of
solute released suggested that solute release is not strongly dictated by solubility. This
is an extremely useful property due to the low water solubility of many pharmaceuticals
(especially biologics) and other desired solutes.
3.3.5. Release of three proteins at room temperature
Release of three model protein solutes of varied sizes, viz. cytochrome c (12
kDa), α-chymotrypsinogen (25.6 kDa), and transferrin (80 kDa) were analyzed from
sheared and non-sheared hydrogels at room temperature. It was found that the effect of
shearing a hydrogel varied significantly between different solutes (Figure 3.8).
Cytochrome c (12 kDa) and transferrin (80 kDa) exhibited similar release. Sheared and
non-sheared hydrogels exhibited significant release of both cytochrome c and
transferrin proteins. Release from sheared hydrogels was slightly greater for both
proteins. This is comparable to observed BSA release, indicating that protein size is not
a primary factor in release. Notably, α-chymotrypsinogen (25.6 kDa) exhibited
significantly lower release from non-sheared than from sheared hydrogels. While
cytochrome c, transferrin, and (to a lesser extent) BSA are all somewhat water soluble
(i.e. 40-200 mg/mL), α-chymotrypsinogen is only sparingly soluble. Therefore, without
occurrence of shearing, the hydrogel network was a highly favorable environment for αchymotrypsinogen. Upon shearing, however, α-chymotrypsinogen exhibited comparable
release to other proteins examined. Therefore, in cases where desired solutes are not
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water soluble, a sheared application (such as injection) could be used to stimulate
release.

Figure 3.8. Release profiles of cytochrome c (12 kDa), α-chymotrypsinogen (25.6 kDa),
and transferrin (80 kDa) from pH 5.5, 300 mM TRIS sheared and non-sheared
hydrogels.
3.3.6. Enantio-preferential release of D-tryptophan at 37 °C
NaDC has long been known to form chiral micelles in aqueous solutions.29,30
Tryptophan was chosen as a model chiral drug for investigating the chirality of
NaDC/TRIS hydrogels. Hydrogels loaded with 5 mM L- or D- tryptophan released Dtryptophan with remarkable enantio-preference (Figure 3.9). D-tryptophan was
substantially released from the hydrogel, while L-tryptophan had approximately zero
release. Complete retention of one enantiomer is immensely desired in the case of
molecules with a toxic enantiomer. It is useful to note that the enantio-preference of Dtryptophan released was from the native gel state with no additional chiral selectors or
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modifiers. Known chirality of NaDC micelles was therefore retained or enhanced in
formation of NaDC/TRIS hydrogels. Net chirality of the hydrogel network thereby
facilitated enantio-preferential release of D-tryptophan.
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Figure 3.9. Absorbance of L- and D- tryptophan released from a hydrogel system at 37
°C.
3.3.7. Ibuprofen release: effect of loaded concentration and enantio-inversion
In addition to high water content and sustained release properties, hydrogels can
also be useful to pharmaceutical applications due to the presence of hydrophobic
domains in the hydrogel network. Although the human body is primarily an aqueous
environment, most pharmaceuticals are water insoluble. The hydrophobic domains of a
hydrogel can help to suspend hydrophobic drugs (if not dissolve them) and prevent
crystallization and precipitation. In this regard, hydrogels can enhance bioavailability of
drugs.
Ibuprofen, a common chiral analgesic, has very low water solubility (102 µM at
25 °C). Thus, ibuprofen was chosen to demonstrate the compatibility of this enantio87

preferential release system with the inherent benefit of hydrophobic domains in hydrogel
delivery systems. Figure 3.10A shows the release of R- and S-ibuprofen at two different
concentrations, viz. the maximum water soluble concentration (102 µM) and ten times
the maximum water soluble concentration (1020 µM). Despite loaded concentration
extending well beyond water solubility, enantio-preference was not lost in ibuprofen
release. Chirality of the hydrogel network should be unaffected by loaded ibuprofen.
Despite lack of solubility in water, ibuprofen was sufficiently dispersed throughout the
hydrogel network to sample network chirality. Preservation of enantio-preferential
release well above the level of solubility is of the utmost importance for practical use of
NaDC/TRIS hydrogels as enantio-preferential drug delivery vehicles due to the low
solubility of many pharmaceuticals.
Perhaps the most significant finding presented here is the ability to invert the
enantio-preference of this release system. I found that through the addition of 5 mM γcyclodextrin to the hydrogel matrix, enantio-preference was reversed (Figure 3.10B).
That is, with the addition of 5 mM γ-cyclodextrin, S-ibuprofen (loaded at 97 µM) was
preferentially released. This preference was opposed to the preferential release of Ribuprofen from the native gel. The amount of R-ibuprofen released from a native gel had
an absorbance of 0.44 ± 0.039, whereas release from a gel with 5 mM γCD had an
absorbance of 0.27 ± 0.0066. S-ibuprofen was quantitatively opposite. It was released
to an absorbance of 0.24 ± 0.021 from a native gel and 0.49 ± 0.0075 from a gel with 5
mM γCD. Since γCD was added to the solution prior to gelation, it is likely incorporated
into the hydrogel network upon gelation through hydrogen bonding, hydrophobic
interactions, and other non-covalent interactions. Incorporation of γCD seemingly
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reversed net chirality of the network in such a manner as to sufficiently reverse enantiopreference. Further investigation of this interesting quantitative similarity of enantiomeric
releases may yield more information on the mechanism of the enantio-preferential
release process.
Enantio-preference inversion is extremely significant due to the fact that the
desired enantiomer may not be the enantiomer released from a native gel. For example,
the S enantiomer may be beneficial while the R enantiomer is the one preferentially
released. This monumental finding of facile enantio-inversion can greatly reduce the
time, cost, and expertise required in the synthesis of enantio-selective drug delivery
vehicles. To the best of our knowledge, the simplicity of this inversion is unprecedented.

Figure 3.10. Release of ibuprofen at 37 °C. A) Two concentrations: 102 µM (maximum
solubility) and 1020 µM (10x maximum solubility). Enantio-preference is retained well
above water solubility of ibuprofen. B) Enantio-inversion of release from hydrogels
modified with 5 mM γ-cyclodextrin.
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3.4. Conclusions
NaDC/TRIS hydrogels were investigated for use as solute delivery vehicles.
Temperature, hydrogel formulation, solute loading concentration, solute solubility, time,
and application of shear force were all found to be factors in the amount of solute
released. Increased temperature was found to reduce differences between release from
sheared and non-sheared hydrogels. Hydrogel formulation was found to affect release
differently at different temperatures and for different solute sizes. Solute release was
found to be linearly proportional to concentration of solute loaded, ideal for calculating
dosages. Sodium deoxycholate/TRIS-based hydrogels were also found to be useful as
enantio-preferential release systems. With the addition of γ-cyclodextrin to the hydrogel
network, I was able to invert enantio-preference: R-ibuprofen was preferentially
released from a native gel, while S-ibuprofen was preferentially released from a
modified gel. Ergo, the presented hydrogel system has exceptional potential for a wide
variety of applications in which one enantiomer is desired over the other. When the
inherent benefits of hydrogels are considered with the additional benefits of the
presented system, these NaDC/TRIS hydrogels are a significant addition to the current
library of solute delivery systems.
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CHAPTER 4.
NOVEL FLUORESCENCE-BASED RATIOMETRIC NANOSENSOR FOR
SELECTIVE IMAGNG OF CANCER CELLS
4.1. Introduction
Extracellular and intracellular pH sensing are important tasks due to fluctuation of
pH with conditions such as cancer and bacterial infections. Healthy extracellular pH is
generally between 5.5 and 7.4. However, extracellular pH in healthy individuals can be
lowered due to renal failure, acidosis, COPD, and many other conditions.1,2 Intracellular
pH is tightly regulated by both normal and cancerous cells with typical values of 7.07.4.3 Therefore, an extracellular pH sensor would be an effective diagnostic tool for pHaffecting conditions. Such pH sensors are also of great importance to agricultural,4
environmental,5 biological,6 and food manufacturing applications. For instance, the dairy
industry requires pH sensing for several processes such as to check freshness of milk,
bacterial conversion of lactose to lactic acid in yogurt, cheese production, and so on.7
The importance of pH sensing has led to development of many types of sensors such
as

potentiometric

sensors,8

electrolyte–insulator–semiconductor

sensors,9

and

fluorescent sensors. Fluorescent pH sensors are of particular interest owing to high
sensitivity, selectivity, and speed inherent to fluorescence measurements.10,11
Nanomaterials can be used to enhance many such pH sensors by facilitating
manipulation of solubility, fluorescence intensity, and combination of multiple beneficial
components.12 Furthermore, nanoscale pH sensors are important for intracellular pH
sensing because they can be used with minimal invasion and can be synthesized in a
size-controlled process for optimum cellular uptake.13
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Common designs of nanoscale fluorescent pH sensors include incorporation of
fluorescent moieties into different nanoparticle matrices made up of polymer,14,15
silica,16,17 etc. Microemulsion approach has also been applied for formation of pHsensitive fluorescent nanoparticles.18 Regardless of the method used to synthesize
nanoparticles, several properties are required from an ideal nanoparticle-based pH
sensor depending on the application. As an example, for cellular pH sensors, one of the
important properties is that the range of pH sensing ability should encompass pH values
relevant to the biological systems of interest.19 Additionally, sensing should not be
inhibited by components within the cell, such as calcium and sodium ions.20 Typical
fluorescence-based pH sensing techniques are impacted by variables such as source
intensity, photobleaching, and path length of the measurement. These variables require
calibration of sensing systems for accurate measurements.21 The need for calibration is
an especially large deficiency for cellular studies due to variation in path length between
different parts of the cell and between different cells.22
Fluorophores with two emission peaks can be used to overcome calibration
needs. Ratiometric responses (i.e. the emission intensity ratio between the two peaks)
can be achieved using a single fluorophore with varied acidic and basic emission,23 two
fluorophores that exhibit pH-dependent Fӧrster resonance energy transfer (FRET),24 or
one fluorophore with pH-dependent emission and one fluorophore with pH-independent
emission.25 Ratiometric measurements provide an intrinsic calibration that is inert to
typical sensitivities of cellular fluorescent measurements.
Despite many and varied needs for pH sensors, there is still significant need for
inexpensive pH sensors with straightforward synthesis.26 A group of uniform materials
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based on organic salts (GUMBOS) are solid phase ionic materials renowned for their
tunability and broad applicability, possibly including as pH sensors.27 Potential
GUMBOS applications vary from photosensitizers in solar cells,28 use in OLEDs,29
sensing applications,30,31 cancer treatment,32 and beyond. In this study, I demonstrate a
three-component, nanoscale, fluorescent GUMBOS as a pH sensor probe derived from
fluorescein (FL), rhodamine B (RhB), and tetradecyltrihexyl phosphonium ions (P66614),
called [P66614][RhB][FL]. Cationic P66614 was chosen for its significantly hydrophobic
quality that is necessary for nanoparticle formation in aqueous media. Anionic
fluorescein and cationic rhodamine B were selected for their satisfactory spectral
overlap that is essential for FRET, where fluorescein serves as donor and rhodamine B
works as acceptor. Intermolecular distance between donor and acceptor is critical and
should be less than 10 nm for efficient FRET.33 By incorporating these ions into a
GUMBOS, the intermolecular distance between donor and acceptor is sufficiently
reduced compared to mixing of two separately prepared solutions of fluorescein and
rhodamine B. Different FRET efficiencies will result in different ratios of fluorescence
emission peaks. Hence, ratiometric analysis can easily be performed on fluorescence
emission peaks of [P66614][RhB][FL]. Nanoparticles of [P66614][RhB][FL] yielded an
intrinsically calibrated fluorescence method for pH distinction between pH values of 4
and 7. This three-component nanoGUMBOS was also found to be preferentially taken
up by cancer cells, providing a fast visual detection method. NanoGUMBOS of
[P66614][RhB][FL] are herein characterized and analyzed for use as pH-sensing and
cancer imaging agents.
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4.2. Materials and methods
4.2.1. Materials
Disodium fluorescein (≥97.5%), rhodamine B (≥95%), and tetradecyltrihexyl
phosphonium chloride ([P66614][Cl]) (≥95%) were purchased from Sigma Aldrich and
used as received. Dichloromethane (DCM) (≥99.9%) was purchased from Fisher
Scientific and used as received. Water used in all experiments is triply deionized (18
MΩ cm) and obtained from an Aries Filterworks high-purity water system.
4.2.2. Synthesis of GUMBOS
[P66614][RhB][FL] GUMBOS was synthesized using a stepwise reaction. Initially,
[P66614][FL] GUMBOS was synthesized based on procedure described elsewhere.34
Thereafter, the required [P66614][RhB][FL] GUMBOS was synthesized by ion exchange.
The comprehensive reaction scheme can be found in Figure 4.1. In brief, disodium
fluorescein was dissolved in pH 5.5 citrate buffer resulting in a mono-anionic species. In
a 1:1.1 molar ratio (P66614:FL), [P66614][Cl] in dichloromethane (DCM) was added to
aqueous fluorescein and allowed to stir 48 hours. After stirring, fluorescein could be
seen prominently in the DCM layer. Excess fluorescein remained unreacted as
evidenced by slight coloration of the water layer. This transfer suggested that
fluorescein ionically associated with the phosphonium cation to form a water insoluble
salt. The DCM layer was washed several times with water to remove excess unreacted
fluorescein and NaCl byproduct. Aqueous rhodamine B was added in a 1.1:1 molar ratio
(rhodamine B:[FL][P66614]) and left to stir 48 hours until rhodamine B was no longer
prominent in the water layer. The water layer containing unreacted excess rhodamine B
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Figure 4.1. Reaction scheme of [P66614][RhB][FL] GUMBOS synthesis. ESI-MS peaks
with m/z 331, 443, and 521 confirmed the presence of the three expected components
in the final product.
was removed. The DCM layer was washed with water several times to remove any
unreacted rhodamine B and byproduct. The final product was obtained by removing
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DCM through rotary evaporation. The sample was subsequently lyophilized to remove
any water.
Synthesis of [P66614][RhB][FL] GUMBOS was confirmed by Bruker 400 Nanobay
NMR (Figure 4.2). Thermal gravimetric analysis was performed using a TA Instruments
TGA 2950 (TA Instruments, New Castle, DE).
4.2.3. Synthesis of nanoGUMBOS
NanoGUMBOS were synthesized using a reprecipitation method in which 60 µL
of 1 mM ethanolic GUMBOS was added to 3 mL water under sonication. For pH
studies, nanoGUMBOS synthesized in water were injected into buffer of desired pH for
a final concentration of 2 µM. Size and morphology of resulting nanoGUMBOS were
characterized using a JEOL1011CX transmission electron microscope (JEOL USA, Inc.,
Munich, Germany).
4.2.4. Spectroscopic studies of GUMBOS and nanoGUMBOS
Absorbance studies were performed using a Shimadzu UV-3101PC UV-vis-NIR
scanning spectrometer (Shimadzu, Columbia, MD). Quartz cuvettes (Starna cells) with
a 0.4 cm path length were used for all spectral analyses. For acquiring absorbance
spectra, an identical cell was filled with water or buffer, as the case may be, and used
as reference. Fluorescent emission spectra were obtained using a Fluorolog-3
spectrofluorimeter (model FL3-22TAU3; HORIBA Scientific, Edison, NJ) with 1 nm slit
widths using right angle geometry.
4.2.5. Cell culture
Normal human breast fibroblast (Hs578BST, ATCC no. HTB-125) and human
breast carcinoma (Hs578T, ATCC no. HTB-126) cell lines were obtained from American
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Figure 4.2. NMR comparison (expanded spectra) of [P66614][RhB][FL] GUMBOS with
parent compounds (DMSOd6 as solvent).
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Type Culture Collection (ATCC, Manassas, VA) and grown to 90% confluence as per
the instructions.
4.2.6. Fluorescence microscopy
Five thousand cells of each cell line (normal breast and breast carcinoma) were
plated in 3 mL of cell media on a 25 mm glass bottom petri dish (10 mm micro cell;
Ashland, MA, USA) and incubated for 24 h. Following incubation, the cell culture media
was replaced by cell media containing suspended 25 nM [P66614][RhB][FL]
nanoGUMBOS and incubated for an additional 30 min. Fluorescence microscopy
images were captured with a 40X dipping objective lens with a TRITC fluorescence filter
and DIC polarization. All fluorescence images were captured with a 5000 s exposure
time for consistency.
4.3.

Results and discussion

4.3.1. Spectroscopic characterization of synthesized GUMBOS
In addition to NMR confirmation and supporting ESI (Figure 4.1 and 4.2),
GUMBOS synthesis can be supported by comparing UV-vis absorbance and
fluorescence spectra of parent dyes and GUMBOS. The absorbance spectrum of
[P66614][RhB][FL] GUMBOS retained all spectral features of parent dyes fluorescein and
rhodamine B (Figure 4.3). However, the absorbance of FL at 505 nm is significantly
reduced in [P66614][RhB][FL] compared to native FL and shoulders in the absorption
spectrum of [P66614][RhB][FL] at approximately 430 and 450 nm were present.
Absorbance of [P66614][RhB][FL] between 400 and 520 nm corresponds to the known
absorbance spectrum of mixed protolytic forms of FL (viz. cationic, neutral,
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monoanionic, and dianionic).35 Reduced absorbance at 505 nm further supports that
multiple FL species (i.e. protolytic forms) exist within the three-component GUMBOS.
Absorbance of parent dye RhB was not significantly impacted by incorporation into
[P66614][RhB][FL]. Stability of RhB absorbance in [P66614][RhB][FL] indicates that
GUMBOS formation is not likely to inhibit FRET acceptance.
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Figure 4.3. Normalized UV-vis absorbance spectra of ethanolic solutions: 10 µM of
parent dye rhodamine B, 10 µM of the parent dye fluorescein, a mixture containing 10
µM each of rhodamine B and fluorescein, and 10 µM [P66614][RhB][FL] GUMBOS.
Fluorescence

spectroscopy

was

used

to

further

verify

synthesis

of

[P66614][RhB][FL] GUMBOS (Figure 4.4). Fluorescence emission of individual parent
dyes was somewhat affected by the presence of the other fluorophore in solution. That
is, a solution with 10 µM each fluorescein and rhodamine B showed fluorescence
emission in which the fluorescein peak intensity was slightly quenched while RhB
emission was enhanced, indicating a slight occurrence of FRET. Fluorescence emission
of the mixture exhibited no peak shift compared to separate fluorophore solutions of 10
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µM each. When the two dyes were incorporated into a GUMBOS with P66614, the
fluorescence emission peak corresponding to fluorescein was reduced significantly,
much more so than in free solution. This reduction in emission is likely due, in part, to
reduced absorbance of [P66614][RhB][FL] GUMBOS at the excitation wavelength.
Furthermore, emission of [P66614][RhB][FL] at 565 (band corresponding to rhodamine B)
was more intense than at 520 nm (band corresponding to fluorescein). The change in
intensity ratios suggested that formation of GUMBOS reduced the distance between
fluorescein and rhodamine B sufficiently for significant FRET to occur.
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Figure 4.4. Normalized fluorescence spectra of 10 uM ethanolic solutions of fluorescein,
rhodamine B, fluorescein and rhodamine B, and [P66614][RhB][FL] GUMBOS. λex = 495
nm.
4.3.2. Spectral overlap integral of fluorescein and rhodamine B
In addition to limited spatial distance, another condition for FRET to occur is
sufficient spectral overlap between emission spectrum of donor and absorbance
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spectrum of acceptor. A high spectral overlap indicates the possibility of high FRET
efficiency. Calculation of spectral overlap integral was performed using the following
equation:

where ε is the molar extinction coefficient of acceptor species (cm-1M-1),

(λ) is the

normalized emission intensity of donor, and λ is the wavelength. Fluorescein (donor)
and rhodamine B (acceptor) were chosen because they have significant spectral
overlap, calculated to be J(λ) = 4.88 1015 M-1cm-1nm4 under studied experimental
conditions (Figure 4.5).

Figure 4.5. Spectral overlap of normalized fluorescein emission and rhodamine B
absorbance. Shaded area indicates spectral overlap (J(λ)).
4.3.3. Energy transfer efficiency of [RhB][FL][P66614] GUMBOS
Energy transfer efficiency (E) was calculated using the following equation:
%
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where Fda is the fluorescence intensity of donor in presence of acceptor and Fd is the
fluorescence intensity of donor in absence of acceptor. E quantifies the percent of
energy emitted by donor that is subsequently absorbed by acceptor. A higher value of E
indicates a more efficient FRET pair. For calculation of E relevant to this study,
ethanolic fluorescein was used for Fd determination, and [P66614][RhB][FL] GUMBOS
was used for Fda determination. Energy transfer efficiency was calculated to be 66% in
[P66614][RhB][FL] GUMBOS, further demonstrating occurrence of FRET.
4.3.4. Spectroscopic analysis of nanoGUMBOS
Spectroscopic analyses were performed on [P66614][RhB][FL] nanoparticles
suspended in pure water to understand the formation of nanoGUMBOS and for later
comparison with pH-adjusted water. I found that in pure water, the nano[P66614][RhB][FL]
absorbance spectrum (Figure 4.6) retained all features of parent dyes. However, the
absorbance value was significantly decreased in nanoGUMBOS compared to parent
dyes. Decreased and broadened absorbance is not unexpected with nanoparticle
formation and can be attributed to aggregation, absence of motional narrowing, and
asymmetrical molecular arrangement (lattice disorder).28,36,37,38
Fluorescence emission spectra of parent dyes and nanoGUMBOS were obtained
with an excitation wavelength of 495 nm, i.e. maximum absorbance of FL, in order for
FRET to occur (Figure 4.7). As expected, RhB had a significantly lower fluorescence
emission than FL due to low absorbance of RhB at 495 nm. When an aqueous solution
containing FL and RhB was excited at this wavelength, FL emission was quenched
approximately 9% (from 761,000 to 696,000 a.u.). Emission intensity corresponding to
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RhB emission maximum (λ = 575 nm) is apparently enhanced from 25,500 to 91,100
a.u. this emission was purely the sum of molecular fluorescein and rhodamine B
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Figure 4.6. Normalized absorbance spectra of aqueous parent dyes fluorescein and
rhodamine B in separate solutions, a solution containing both parent dyes, and
[P66614][RhB][FL] nanoGUMBOS in water.
emissions. Lack of enhancement in rhodamine B emission suggested that an aqueous
solution containing molecular fluorescein and rhodamine B did not undergo significant
FRET. It can be discerned that FL and RhB were oriented in aqueous solution in a way
that inhibited FRET. NanoGUMBOS suspended in water and excited at 495 nm
exhibited significantly decreased fluorescein emission. Fluorescein incorporated into
nanoGUMBOS had emission quenched to 78% of fluorescein emission in free solution.
Rhodamine B emission was enhanced over 14 fold as a component of nanoGUMBOS
(from 25,400 a.u. in free solution to 359,000 a.u. in nanoGUMBOS). Fluorescence of
[P66614][RhB][FL] nanoparticles in water also featured a distinct emission band for
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rhodamine B emission at 570 nm that was not seen in a solution with a mixture of
fluorescein and rhodamine B when excited at 495 nm. Spectral properties thus indicated
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Figure 4.7. Normalized fluorescence emission spectra of aqueous parent dyes
fluorescein and rhodamine B in separate solutions, a solution containing both parent
dyes, and [P66614][RhB][FL] nanoparticles in water. λex = 495 nm.
that in aqueous solutions, nanoparticles of [P66614][RhB][FL] underwent FRET. The
occurrence of FRET suggested that this three-component GUMBOS may be suitable as
a FRET-based sensor.
4.3.5. Effect of pH on spectral properties of [P66614][RhB][FL] nanoGUMBOS
Absorbance spectra of [P66614][RhB][FL] nanoparticles at a wide range of pH
values yielded information about the form of fluorescein present at each pH (Figure
4.8A). The absorbance band at 550 nm corresponds to the rhodamine B component of
the nanoGUMBOS and remains largely unchanged across all investigated pH values.
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This pattern is comparable to known absorbance properties of molecular rhodamine B.39
Therefore, any pH-dependent changes in rhodamine B emission can be attributed to
association of rhodamine B with fluorescein and P66614. In practical applications of
fluorescence-based measurements, a single excitation wavelength with dual emission
wavelengths is typically more feasible than a dual excitation wavelength.40 For this
reason, I excited [P66614][RhB][FL] nanoparticles at a single wavelength, viz. 495 nm,
and examined resulting emission at seven pH values (Figure 4.8B).
At pH 2, [P66614][RhB][FL] nanoparticles yielded an absorbance band at 437 nm.
This band was indicative of cationic fluorescein.35 Interestingly, [P66614][RhB][FL]
nanoparticles at pH 2 did not exhibit any other absorbance bands attributed to
fluorescein. This spectrum suggested that at pH 2, cationic fluorescein was the primary
species in [P66614][RhB][FL] nanoGUMBOS. The fluorescence emission band of
[P66614][RhB][FL] nanoparticles at pH 2 was significantly lower than at other pH values.
This low emission was largely due to low absorbance of [P66614][RhB][FL] at the selected
excitation wavelength of 495 nm (characteristic of cationic fluorescein). The rhodamine
B emission band in nano[P66614][RhB][FL] was significantly higher than in the parent dye
alone

indicating

occurrence

of

FRET.

The

fluorescein

emission

band

of

nano[P66614][RhB][FL] in pH 2 buffer was approximately 15 nm red-shifted from that of
the parent compound. This shift was most likely due to J-aggregation (i.e. head-to-tail
stacking).41
Absorbance of [P66614][RhB][FL] at pH 4 featured very little indication of
fluorescein present. Molecular fluorescein with neutral charge is known to exhibit very
low absorbance (relative to charged forms) between approximately 430 and 480 nm.42
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Figure 4.8. Spectral properties of [P66614][RhB][FL] nanoGUMBOS in buffers of seven
distinct pH values. A) Absorbance spectra B) Fluorescence emission spectra. λex = 495
nm.
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There was a broad absorbance band of very low intensity (between 0.05 and 0.1 units)
from 460-490 nm that indicated slight absorbance of monoanionic fluorescein.
Molecular fluorescein has a pKa of 4.31 for the transition from neutral to monoanionic
form. Because pH 4 is close to the pKa of fluorescein it was not unexpected to see
spectral contributions from both the neutral and monoanionic species. A previous study
by Das et al. also demonstrated stable nanomaterials derived from fluorescein-based
ionic materials with multiple protolytic forms of fluorescein present.34 Emission of
nano[P66614][RhB][FL] at pH 4 was comparable to that at pH 2. The fluorescein band
was again low intensity and red-shifted compared to the parent dye and to other pH
values. Low emission was again due to low absorbance as described earlier.
The [P66614][RhB][FL] nanoparticles absorbed broadly at pH 5. Absorbance was
relatively low (viz. between 0.1 and 0.2) and broad across the known absorbance
wavelengths of fluorescein. This spectrum and known fluorescein pKa values suggested
that at pH 5, monoanionic form of fluorescein was present in nano[P66614][RhB][FL].43
Fluorescence emission at fluorescein band (515 nm) increased from that of more acidic
pH values due to increased absorbance of the monoanionic form and correspondingly
higher molar extinction coefficient at the chosen excitation wavelength.42 Emission at
rhodamine B band (575 nm) was also increased from the more acidic environment of
pH 2. This emission is not expected to change with pH when excited at 495 nm.
Therefore, this increase can be attributed to increased FRET resulting from more
intense fluorescein emission. Emission at pH 5 was not significantly shifted from parent
compound emission indicating that J-aggregates were not prevalent at this pH. It has
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previously been demonstrated that the protolytic form of fluorescein participates in
directing prevalence and type of aggregation (i.e. J or H). 34
The absorbance spectrum of nano[P66614][RhB][FL] at pH 6 was similar in
broadness and intensity to the spectrum at pH 5 with two exceptions: At pH 6 there was
a slight increase (0.02 units) in the absorbance band at 485 nm and a significant
decrease in apparent shouldering from rhodamine B around 510 nm. Fluorescein has a
pKa of 6.45 between mono- and di-anionic forms. Proximity of pH 6 to this pKa resulted
in multiple fluorescein species as seen in the absorbance spectrum. Emission of
nano[P66614][RhB][FL] at pH 6 was significantly higher than at pH 5 for the fluorescein
band despite comparable absorbance at the excitation wavelength. Dianionic
fluorescein has significantly more intense fluorescence than monoanionic fluorescein.43
Therefore, increased fluorescence intensity was likely due in part to the presence of
dianionic

fluorescein

in

nano[P66614][RhB][FL]

at

pH

6.

The

emission

band

corresponding to rhodamine B was only slightly more intense than that of pH 5. This
contrast in spectra strongly suggested that FRET decreased at pH 6. TEM images
revealed that at pH 6, nano[P66614][RhB][FL] had slight solubility. Expansion of
nanoparticles at this pH increased distance between fluorescein and rhodamine B
components to reduce the efficiency of FRET. Decreased FRET would also have
contributed to a more intense (less quenched) emission at the fluorescein band.
Spectral properties of nano[P66614][RhB][FL] did not differ significantly between
pH values of 7 and 10. Between these pH values, molecular fluorescein remains
dianionic. The intense absorbance band at 495 nm indicated that dianionic fluorescein
was the primary species present in nanoGUMBOS at these pH values. As predicted,
111

intense absorbance at the excitation wavelength resulted in significantly more intense
fluorescence emission at 510 nm than seen in other pH values. The fluorescence band
corresponding to rhodamine B was almost twice the intensity of the band in more acidic
environments. However, intensity of rhodamine band was only 60% of the fluorescein
band. Varied absorbance of fluorescein within [P66614][RhB][FL] nanoparticles at
different pH values and apparent differences in fluorescence intensities suggested that
this GUMBOS can be used for pH-dependent emission using a single excitation
wavelength.
Ratiometric calculations can be used for intrinsically calibrated determination of
pH as previously discussed.44,45 The ratio of intensities was calculated between 512 nm
and 575 nm. As depicted in Figure 4.9, linearity of ratiometric pH response of
[P66614][RhB][FL] nanoparticles was between approximate pH values of 5 and 7. This pH

2.5

I512/I575 emission

2
1.5
1
0.5
0
1

3

5

7

9

11

pH

Figure 4.9. Ratio of fluorescence emission intensities at 512 nm and 575 nm. These
wavelengths correspond to emission from the fluorescein component and rhodamine B
component, respectively.
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range aligns well with the desire for cellular pH determination. Ratiometric analysis
cannot be used with this material to differentiate pH values between 2 and 4, or
between 7 and 10. However, this material can be used for qualitative analysis of pH
values lower or higher than the linear range. For example, a ratio of 0.22 could indicate
acidity too high for normal cells, but not quantify pH of the cells.
4.3.6. Size analysis of [P66614][RhB][FL] nanoGUMBOS
Nanoparticles derived from [P66614][RhB][FL] were synthesized in pure water
using a reprecipitation method. As can be seen from Figure 4.10A, uniform size
distribution of nanoparticles with average size 4.4 ± 0.7 nm was observed from TEM
micrograph analysis. When these particles were injected into buffer solutions at various
pH values, size distribution of nanoparticles was found to differ between different
environmental acidities, especially at extreme pH values (viz. 2 and 10). It has
previously been shown that both the protolytic form of fluorescein34 (where applicable)
and several types of interactions (covalent and noncovalent)46 impact molecular
arrangement of nanoparticles and can impart pH-induced size changes. At pH 2,
molecular fluorescein exists in in the cationic form.42 [P66614][RhB][FL] nanoparticles
injected into pH 2 buffer coalesce into significantly larger particles of 69.7 ± 8.1 nm
(Figure 4.10B). Relatively large nanoparticles suggested that presence of cationic
fluorescein (as seen in absorbance spectrum, Figure 4.8A) exhibited sufficient repulsion
with P66614 cations to increase particle size. Such changes in size due to intraparticle
interactions with pH were previously described in detail.34 Despite this significant size
and repulsion increase, particles are uniformly sized with spherical shape.
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Between pH 4 and 8, [P66614][RhB][FL] nanoparticle size was not significantly
altered upon injection into buffer solutions (relative to suspension in water).
Nanoparticles at pH 4 were found to be 4.3 ± 0.7 nm (Figure 4.10C). Molecular
fluorescein would be neutral at this pH value. The presence of neutral fluorescein
species is supported by the absorbance spectrum (Figure 4.8A). Interestingly, no
significant size difference was observed at pH 4 compared to pure water. Neutral
fluorescein would not be expected to have significant intraparticle repulsion effects with
cationic components. Therefore, size preservation further supported the theory that
nanoparticle size is partially driven by the protolytic form of fluorescein and the resulting
intraparticle interactions.
Between

pH

values

of

5

and

6

molecular

fluorescein

would

be

monodeprotonated. Nanoparticles of [P66614][RhB][FL] were found to aggregate into a
network of material at these pH values (Figure 4.10D, E). Within many of these
networks of material, particles of approximately 4-5 nm were retained. However,
boundaries of nanomaterials were indistinct. At these pH values, [P66614][RhB][FL]
appeared to be slightly soluble, thereby decreasing nanoparticle stability. A buffer of pH
7 resulted in distinct particles embedded in a network of material (Figure 4.10F).
However, at pH 7 particles could be more clearly distinguished from surrounding
network than at pH 5 and 6. Average particle size found in the network of pH 7 were
found to be 4.2 ± 0.5 nm, statistically equivalent in size to particles in pure water. A pH
value of 8 also resulted in particles of similar size and shape (Figure 4.10G) to those
formed in pure water (viz. 3.8 ± 0.6 nm). Molecular fluorescein is dianionic at both pH 7
and 8. The two negative charges strongly interacted with cationic rhodamine B and
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P66614 to retain GUMBOS and nanoparticle association at these pH values. Interestingly,
this size stability was not seen at pH 10 (Figure 4.10H). Basic pH 10 resulted in
coalescence of [P66614][RhB][FL] nanoparticles into larger particles of 71.0 ± 11.0 nm.
The substantial increase in hydroxide ions between a pH 8 solution and a pH 10
solution resulted in a more favorable environment for combination of 4 nm
[P66614][RhB][FL] particles into larger diameter particles.

Figure 4.10. TEM micrographs of [P66614][RhB][FL] nanoGUMBOS in A) pure water, B)
pH 2, C) pH 4, D) pH 5, E) pH 6, F) pH 7, G) pH 8, H) pH 10.
4.3.7. [P66614][RhB][FL] nanoGUMBOS for fluorescence microscopy imaging of
cancer cells
The significant difference between fluorescent peak ratios at pH 5 and pH 7 (0.70
and 2.2, respectively) implied that [P66614][RhB][FL] nanoparticles could be useful for
cancer imaging applications. Fluorescence microscopy filters can be selected to pass
fluorescein emission and rhodamine B emission separately. In this case, measured
intensities (from each filter) can be used to ratiometrically determine pH in situ. This
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analysis is strongly beneficial, not only in cancer detection, but for many human
conditions involved in pH change (e.g. acidosis).
Two cell lines, normal human breast cells and cancerous human breast cells,
were incubated with 25 nM [P66614][RhB][FL] nanoparticles. Control studies were done
with equivalent concentrations of parent dyes (Figure 4.11 A-B). Fluorescence
microscopy images were obtained using a TRITC filter and a DIC polarizing filter. A
clear visual distinction could be made between normal and cancer cells incubated with
nano[P66614][RhB][FL] (Figure 4.11C). Cancer cells exhibited intense fluorescence
throughout the entirety of the cell, except for the nucleus. Normal cells exhibited
significantly less distribution of fluorescence than cancer cells, where only scattered
fluorescence can be seen. Studies of parent dye fluorescein showed that incubation in
normal and cancer cells both resulted in fluorescence throughout the cell. Studies of
parent dye rhodamine B showed that incubation in normal and cancer cells both
resulted in localized fluorescence in the nucleus. Comparison of [P66614][RhB][FL]
nanoGUMBOS to parent dyes revealed that formation of nanoGUMBOS serviceably
causes differentiation of cellular uptake between cancerous and normal cells and,
effectually, observed fluorescence. This substantial visual difference indicated that
[P66614][RhB][FL] nanoGUMBOS can be useful in imaging of cancer cells, especially due
to ease and speed required for visual diagnostic analyses.
4.3.8. Photostability and thermostability of [P66614][RhB][FL]
Photostability is an important characteristic of dyes developed for biomedical
imaging.47,48 High photostability in a material results in longer shelf-life and more
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reproducible measurements over time. As depicted in Figure 4.12A, an exceptional
photostability of [P66614][RhB][FL] GUMBOS was observed with an increase of 170%
over the first 11000 s. From 11000 to 36000 s, photostability was nearly constant at

Figure 4.11. Fluorescence microscopy images of 25 nM parent dyes and sensor in
normal and cancerous breast cells. All images have TRITC and DIC filters applied for
visualization of cells. A) FL, B) RhB, and C) [P66614][RhB][FL] nanoGUMBOS.
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170%. Fluorescein was reduced to 74%, and rhodamine B remained at 98% over the
same time period (Figure 4.12B). However, the lack of photobleaching in case of RhB is
presumably due to insignificant absorbance at the chosen excitation wavelength.
Increased photostability was also observed in previous studies where Lu et al. ascribed
this increase in photostability to laser-induced J-aggregation.34,49 This increase in
fluorescence emission with light exposure is a strong advantage for practical utility of
[P66614][RhB][FL], especially in the case of fluorescence imaging. Thermal stability is
another important characteristic of materials exposed to lasers. Bulk [P66614][RhB][FL]
was found to be thermally stable (90% weight retention) up to 299 °C (Figure 4.12C).
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Figure 4.12. Photostability A) fluorescein and rhodamine B (λex=495 nm). B)
[P66614][RhB][FL] (λex = 495 nm, 550 nm). C) Thermogravimetric analysis of
[P66614][RhB][FL] GUMBOS.
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4.4. Conclusions
In this work, I have shown synthesis of [P66614][RhB][FL], a three-component
GUMBOS derived from fluorescein, rhodamine B, and tetradecyltrihexyl phosphonium.
NanoGUMBOS were found to have consistent size of approximately 4 nm with changes
in pH. However, in the case of very acidic or very basic conditions (i.e. pH 2 and 10
respectively),

particles

were

significantly

larger

(approximately

70

nm).

Nano[P66614][RhB][FL] exhibited pH-dependent spectral properties. Absorbance spectra
of the nanoGUMBOS indicated that the protolytic form of fluorescein within the
nanoparticle corresponded to that of fluorescein in solution. Fluorescence emission of
nano[P66614][RhB][FL] exhibited two bands corresponding to fluorescein and rhodamine
B. Both bands increased with increasing pH due to enhanced absorbance in more
anionic forms of fluorescein and increased FRET, with the exception of pH 6. FRET was
slightly decreased at this pH due to slight solubility. Intramolecular FRET yielded a
fluorescent peak ratio that varied significantly between pH 5 and pH 7, an essential
range for cellular pH sensing. Cancer cells incubated with [P66614][RhB][FL]
nanoparticles were found to have a greater selective distribution of fluorescence over
normal cells incubated with equivalent experimental conditions. Such differentiation
could not be made with equivalently analyzed parent compounds. This visual difference
shows incredible potential for use of [P66614][RhB][FL] nanoGUMBOS in visual diagnosis
of cancer.
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Chapter 5.
Conclusions and Future Work
5.1. Conclusions
In this dissertation, I have outlined the development and exploration of sodium
deoxycholate(NaDC)/TRIS-based hydrogels and a fluorescein/rhodamine B-based
GUMBOS for biomedical applications. In the first chapter, I provide a broad outline of
hydrogels including classification and properties and a brief outline of GUMBOS
applications. Stimuli-responsive hydrogels and drug delivery applications are discussed,
highlighting the idea that each application of hydrogels requires a distinct set of
properties: A hydrogel perfectly suited for one application may be useless in another. To
this point, I discuss a tunable hydrogel system and its potential for applications.
In the second chapter, NaDC/TRIS hydrogels were modified through changes in
pH and [TRIS] of the immobilized solution. It was found that these modifications
significantly affected the properties of this system. For example, by increasing [TRIS]
the number of hydrogen bonding sites is increased. This resulted in increased
crystallinity, mechanical strength, and sol-gel temperature. Structural rigidity of the
hydrogel network was also found to be affected by changes in pH. Fewer hydrogen
bonding sites are present when above the pKa of NaDC, resulting in lower mechanical
strength. Near-IR dyes were used to form GUMBOS. The tunability of these hydrogel
materials allowed for tunable synthesis of nanoparticles from these GUMBOS.
Especially when coupled with the inherent biocompatibility of hydrogels, this could be
particularly useful in imaging applications. Characterization in this chapter can be used
to determine the suitability of these materials to a desired application.
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In the third chapter of this dissertation, I thoroughly examined the application of
solute release. It was found that at room temperature, there is a substantial difference in
the amount of solute released from gels that had and had not been sheared. At the
physiologically relevant temperature of 37 °C, these significant differences were
reduced. This indicates that the mode of delivery must be considered when calculating
the dosage of a gel. Hydrogel formulation, loaded solute concentration, solute solubility,
and time were also found to impact solute release. Drug release was found to increase
linearly with the amount of drug loading, facilitating dosing calculations. NaDC/TRISbased hydrogels were found to have inherent enantio-preferential release. One
enantiomer of model chiral molecules was found to be preferentially released from the
hydrogels when loaded in equal amounts in sister samples. This is extremely beneficial
for drug delivery applications in which the racemic mixture is commercially available but
one enantiomer has unfavorable effects in the body. Through addition of cyclodextrin,
enantiopreferential inversion was possible. This is exceptionally important in cases
where the less desirable enantiomer is released by the native gel. In conjunction with
the inherent biocompatibility of hydrogels and the tunability of this system, native
enantioselectivity provides great potential for the use of these hydrogels in drug delivery
applications.
In the fourth chapter of this dissertation I explored synthesis, characterization,
and potential applications of a three-component nanoGUMBOS, nano[P66614][RhB][FL].
NanoGUMBOS were uniform in size between pH values of 4 and 8 after facile
synthesis. Fluorescein and rhodamine B components of the nanoGUMBOS contributed
to pH-dependent spectral properties. Two fluorescence emission bands were observed
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and increased in intensity with increasing pH due to the protolytic forms of fluorescein
and rhodamine B components. Intramolecular FRET resulted in ratiometric differences
between the emission bands at varied pH levels. Significant ratiometric variation was
found between pH values of 5 and 7, a range highly relevant for cellular pH. In vitro
fluorescence

microscopy

revealed

that

cancer

cells

incubated

with

nano[P66614][RhB][FL] had significantly greater fluorescence distribution than normal
cells incubated equivalently. Such obvious visual differentiation indicates pronounced
potential for use of these nanoGUMBOS in visual cancer diagnosis.
5.2. Future work
Thus far, the potential of these hydrogel materials for use in drug delivery
applications has been discussed at length. However, several more studies must be
performed before their clinical use. Toxicity studies will be critical to ensure successful
use. The components of the hydrogels are deoxycholate (a bile acid), TRIS (a medically
used buffer), and water. Thus, toxicity is expected to be very low. One potential concern
is the surfactant properties of deoxycholate. However, it is anticipated that the assembly
of a gel network will prevent surfactant action. Biodegradation studies will also be
required before clinical application of NaDC/TRIS hydrogels. Particularly due to the
absence of polymers and the natural presence of deoxycholate in the body, I anticipate
that biodegradation will occur acceptably. Finally, in vivo studies will need to be
performed. Drug release profiles may be affected by substituents in the body and
therefore need to be analyzed thoroughly before being used pharmaceutically.
Several modes of delivery were discussed in this work. Future work could include
exploration of nanogels as delivery systems. As the name suggests, nanogels are
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crosslinked (physically in this case) networks on the nanoscale. They typically retain the
beneficial properties of macroscale hydrogels with the additional benefits of
bioavailability. For example, nanogels can be used to transport drugs to difficult places
such as across the blood brain barrier. There are currently many methods for synthesis
of such materials, so it is expected that a suitable method could be found to further
enhance these tunable materials.
Drug delivery was a focus of this dissertation, but it is important to note that
hydrogels can be applied in a wide variety of fields. Especially due to the tunability of
this system, several applications can be explored in the future. Hydrogels can be used
in sensing applications, for example. I have shown that these materials are sensitive to
their environment, can be loaded with many different solutes of different sizes and
properties, and are highly tunable in mechanical strength, crystallinity, and other
properties. This is strong evidence that they may be used effectively in sensing
applications. The biocompatibility and ability to load solutes easily also suggest that
they may be useful in imaging applications. Whether in drug delivery, sensing, or
imaging, future work on NaDC/TRIS hydrogels can involve the choosing of a specific
application. When a desired application is specifically defined, the hydrogels can be
tuned to fit the requirements of that particular application.
Due to the high potential for nano[P66614][RhB][FL] to be used in cancer
diagnoses, future work should be aimed at further understanding the uptake properties
and development of this approach for clinical applications. Primary efforts should be
towards analysis of pH within the cells and in media surrounding the cells. Such
analysis could significantly further the diagnostic ability of this material. Uptake
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mechanism and cytotoxicity studies may reveal further uses of nano[P66614][RhB][FL].
Synthesis of nano[P66614][RhB][FL] was demonstrated to be facile at small scale.
However, for commercial use, scalability studies should be performed. While
photostability and thermostability were found to be favorable, practical storage and
shelf-life studies should be performed for better stability understanding.
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